n 0 Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China Title: The clinical characteristics of 2019 novel coronavirus severe pneumonia *Corresponding Author
n 1 Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
n 2 China through a drug-target interaction deep learning model
n 3 Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China
n 4 Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm
n 5 Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage
n 6 MERS-CoV spillover at the camel-human interface
n 7 Identification of a super-spreading chain of transmission associated with COVID-19
n 8 Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
n 9 Clinical Characteristics of Two Human to Human Transmitted Coronaviruses: Corona Virus Disease 2019 versus Middle East Respiratory Syndrome Coronavirus
n 10 Alpha-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication Structure-based design, synthesis, and activity assessment
n 11 Awareness of MERS-CoV among Staff Members of Prince Sultan Military Medical City in Riyadh, Saudi Arabia
n 12 Gender differences in patients with COVID-19: Focus on severity and mortality
n 13 Evolution and variation of 2019-novel coronavirus
n 14 SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability
n 15 Potential Factors for Prediction of Disease Severity of COVID-19 Patients
n 16 Teicoplanin potently blocks the cell entry of 2019-nCoV
n 17 Bat-man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations
n 18 A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm
n 19 Host Determinants of MERS-CoV Transmission and Pathogenesis
n 20 Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia
n 21 Tissue tropism and transmission ecology predict virulence of human RNA viruses
n 22 Adaptive evolution of bat dipeptidyl peptidase 4 (dpp4): implications for the origin and emergence of Middle East respiratory syndrome coronavirus
n 23 Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases
n 24 Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis
n 25 Knowledge and attitude of healthcare workers about middle east respiratory syndrome in multispecialty hospitals of Qassim, Saudi Arabia
n 26 Molecular epidemiology and characterization of human coronavirus
n 27 Perception and Attitude of Emergency Room Resident Physicians toward Middle East Respiratory Syndrome Outbreak
n 28 MERS coronavirus: diagnostics, epidemiology and transmission
n 29 Coronaviruses: emerging and re-emerging pathogens in humans and animals
n 30 Replication of MERS and SARS coronaviruses in bat cells offers insights to their ancestral origins
n 31 Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4 OPEN
n 32 Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease
n 33 A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design
n 34 Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
n 35 Ecological niche modeling to determine potential niche of Vaccinia virus: a case only study
n 36 Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
n 37 Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
n 38 SCIENCE CHINA SPECIAL TOPIC: Haunted with and hunting for viruses Emerging infectious diseases associated with bat viruses
n 39 Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus
n 40 The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line
n 41 Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region Comment on "Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward" Commentary
n 42 Lung ultrasound imaging in avian influenza A (H7N9) respiratory failure Lung ultrasound imaging in avian influenza A (H7N9) respiratory failure
n 43 Molecular Sciences Editorial Molecular Research on Emerging Viruses: Evolution, Diagnostics, Pathogenesis, and Therapeutics
n 44 pathogens A Comprehensive Review of Common Bacterial, Parasitic and Viral Zoonoses at the Human-Animal Interface in Egypt
n 45 Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)
n 46 Polyphyletic origin of MERS coronaviruses and isolation of a novel clade A strain from dromedary camels in the United Arab Emirates
n 47 The Porcine Deltacoronavirus Replication Organelle Comprises Double-Membrane Vesicles and Zippered Endoplasmic Reticulum with Double-Membrane Spherules
n 48 Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
n 49 Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2
n 50 Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness
n 51 The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species
n 52 Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015
n 53 a database of geopositioned Middle East Respiratory Syndrome Coronavirus occurrences
n 54 Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
n 55 An assessment of the level of concern among hospital-based health-care workers regarding MERS outbreaks in Saudi Arabia
n 56 Evaluation and comparison of statistical methods for early temporal detection of outbreaks: A simulation-based study
n 57 Isolation and Characterization of Dromedary Camel Coronavirus UAE-HKU23 from Dromedaries of the Middle East: Minimal Serological Cross-Reactivity between MERS Coronavirus and Dromedary Camel Coronavirus UAE-HKU23
n 58 Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice
n 59 MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells
n 60 Absence of Middle East respiratory syndrome coronavirus in Bactrian camels in the West Inner Mongolia Autonomous Region of China: surveillance study results from July 2015
n 61 Coronaviruses cause respiratory and intestinal infections in animals and humans
n 62 Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
n 63 HTCC: Broad Range Inhibitor of Coronavirus Entry
n 64 Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection
n 65 The evidence base of primary research in public health emergency preparedness: a scoping review and stakeholder consultation
n 66 Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome
n 67 Deep Sequencing to Identify the Causes of Viral Encephalitis
n 68 Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross
n 69 Structural and functional characterization of MERS coronavirus papain-like protease
n 70 Risk of transmission via medical employees and importance of routine infection- prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea
n 71 Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
n 72 Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells
n 73 Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai
n 74 Crystal structure of Middle East respiratory syndrome coronavirus helicase
n 75 Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
n 76 viruses Review From SARS to MERS, Thrusting Coronaviruses into the Spotlight
n 77 S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen
n 78 Middle East respiratory syndrome: pathogenesis and therapeutic developments
n 79 The WHO global influenza surveillance and response system (GISRS)-A future perspective
n 80 Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya
n 81 Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
n 82 Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
n 83 Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
n 84 To appear in: One Health
n 85 Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
n 86 Middle East Respiratory Syndrome Coronavirus and the One Health concept
n 87 Translating Lung Microbiome Profiles into the Next- Generation Diagnostic Gold Standard for Pneumonia: a Clinical Investigator's Perspective
n 88 Networking of Public Health Microbiology Laboratories Bolsters europe's Defenses against infectious Diseases
n 89 Genomic Analysis of 15 Human Coronaviruses OC43 (HCoV-OC43s) Circulating in France from 2001 to 2013 Reveals a High Intra-Specific Diversity with New Recombinant Genotypes
n 90 ARTICLE Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
n 91 Viral pathogen discovery
n 92 Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning
n 93 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir
n 94 Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
n 95 4 Ministry of Health, Riyadh, Saudi Arabia. 5 Formerly Ministry of Health
n 96 Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
n 97 Evolutionary Dynamics of MERS- CoV: Potential Recombination, Positive Selection and Transmission OPEN
n 98 Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice
n 99 Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing
n 100 Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody Author summary
n 101 The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus
n 102 Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update
n 103 SCIENCE CHINA SPECIAL TOPIC: Haunted with and hunting for viruses New strategy for virus discovery: viruses identified in human feces in the last decade
n 104 Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10
n 105 Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
n 106 Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016
n 107 Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)
n 108 Autologous Antibody Capture to Enrich Immunogenic Viruses for Viral Discovery
n 109 An Overview of the Most Significant Zoonotic Viral Pathogens Transmitted from Animal to Human in Saudi Arabia
n 110 Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis
n 111 ARTICLE Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1
n 112 First isolation of West Nile virus from a dromedary camel
n 113 Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
n 114 Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome
n 115 Bat origin of human coronaviruses
n 116 Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets OPEN
n 117 Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
n 118 A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination Human infection with Middle East Respiratory
n 119 ARTICLE Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
n 120 Detection of Coronaviruses in Bats of Various Species in Italy
n 121 A Versatile Sample Processing Workflow for Metagenomic Pathogen Detection OPEN
n 122 Case Report Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature
n 123 Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017
n 124 Detection of alpha-and betacoronaviruses in rodents from Yunnan, China
n 125 Asymptomatic Middle East Respiratory Syndrome coronavirus infection using a serologic survey in Korea
n 126 Functional analysis of potential cleavage sites in the MERS- coronavirus spike protein
n 127 Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease
n 128 Detection of new genetic variants of Betacoronaviruses in Endemic Frugivorous Bats of Madagascar
n 129 Prevalence and Genetic Diversity Analysis of Human Coronavirus OC43 among Adult Patients with Acute Respiratory Infections in Beijing
n 130 Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012
n 131 Coronavirus Cell Entry Occurs through the Endo-/ Lysosomal Pathway in a Proteolysis-Dependent Manner
n 132 Identification of diverse viruses in upper respiratory samples in dromedary camels from United Arab Emirates
n 133 A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
n 134 Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control
n 135 Review Article Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
n 136 Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication
n 137 Nucleocapsid protein-dependent assembly of the RNA packaging signal of Middle East respiratory syndrome coronavirus
n 138 CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection
n 139 Inoculation of Goats, Sheep, and Horses with MERS-CoV Does Not Result in Productive Viral Shedding
n 140 Evaluation of preparedness of healthcare student volunteers against Middle East respiratory syndrome coronavirus (MERS-CoV) in Makkah, Saudi Arabia: a cross-sectional study
n 141 SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes
n 142 A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome
n 143 Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
n 144 From SARS to COVID-19: A previously unknown SARS-related coronavirus (SARS-CoV-2) of pandemic potential infecting humans -Call for a One Health approach
n 145 Human Respiratory Coronaviruses Detected In Patients with Influenza-Like Illness in Arkansas, USA HHS Public Access Author manuscript
n 146 Emergence of the Middle East Respiratory Syndrome Coronavirus
n 147 Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection*
n 148 Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt
n 149 Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments
n 150 Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels
n 151 viruses Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
n 152 Development of a recombinant replication- deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice
n 153 Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory
n 154 Middle East respiratory syndrome coronavirus: review of the current situation in the world
n 155 Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform
n 156 Molecular Evolution of MERS Coronavirus: Dromedaries as a Recent Intermediate Host or Long-Time Animal Reservoir?
n 157 Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
n 158 A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
n 159 Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
n 160 Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia
n 161 Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine
n 162 Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria
n 163 Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
n 164 Tropical Medicine and Infectious Disease Potential Intermediate Hosts for Coronavirus Transmission: No Evidence of Clade 2c Coronaviruses in Domestic Livestock from Ghana
n 165 Building International Genomics Collaboration for Global Health Security
n 166 Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection
n 167 Patterns of Human Respiratory Viruses and Lack of MERS-Coronavirus in Patients with Acute Upper Respiratory Tract Infections in Southwestern Province of Saudi Arabia
n 168 Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand
n 169 The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease
n 170 Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases
n 171 Epidemiology and Infection Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study
n 172 Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC
n 173 Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN
n 174 Rapid detection and monitoring of human coronavirus infections
n 175 Consensus statement The species Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses*
n 176 MERS Coronavirus: An Emerging Zoonotic Virus
n 177 Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
n 178 Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
n 179 Scientific RepoRts | 6:18825 | of Korea. 12 The MERS Task Force of the
n 180 and Technology, Nairobi 00200, Kenya 4. Veterinary Services Department, Kenya Wildlife Service, Nairobi 00100, Kenya 5. Mammalogy Section, National Museum of Kenya
n 181 viruses Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
n 182 STUDY PROTOCOL Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Open Access
n 183 SCIENCE CHINA SPECIAL TOPIC: Haunted with and hunting for viruses Haunted with and hunting for viruses
n 184 Treatment of Middle East Respiratory Syndrome with a combination of lopinavir- ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
n 185 Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4- mediated induction of IRAK-M and PPARγ
n 186 The heptad repeat region is a major selection target in MERS- CoV and related coronaviruses OPEN
n 187 DBatVir: the database of bat-associated viruses
n 188 Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
n 189 SCIENCE CHINA SPECIAL TOPIC: Haunted with and hunting for viruses A novel human coronavirus: Middle East respiratory syndrome human coronavirus
n 190 One Health' for the people of Hong Kong and the world
n 191 Awareness of droplet and airborne isolation precautions among dental health professionals during the outbreak of corona virus infection in Riyadh city, Saudi Arabia
n 192 Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein OPEN
n 193 Lack of Middle East Respiratory Syndrome Coronavirus Transmission in Rabbits
n 194 Villains or heroes? The raison d'être of viruses
n 195 Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1
n 196 viruses Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
n 197 Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study
n 198 MERS transmission and risk factors: a systematic review
n 199 Infectious Bronchitis Virus Generates Spherules from Zippered Endoplasmic Reticulum Membranes
n 200 The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation
n 201 Effective inhibition of MERS-CoV infection by resveratrol
n 202 Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
n 203 Genomic Analysis and Surveillance of the Coronavirus Dominant in Ducks in China
n 204 Case Report A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult
n 205 Epidemiology and Infection Temporal dynamics of Middle East respiratory syndrome coronavirus in the Arabian
n 206 viruses Identification of a Novel Betacoronavirus (Merbecovirus) in Amur Hedgehogs from China
n 207 Can long-term historical data from electronic medical records improve surveillance for epidemics of acute respiratory infections? A systematic evaluation
n 208 viruses Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus
n 209 Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
n 210 A Rapid and Low-Cost PCR Thermal Cycler for Infectious Disease Diagnostics
n 211 Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates
n 212 MERS-CoV: Understanding the Latest Human Coronavirus Threat
n 213 Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD
n 214 MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-a treatment
n 215 A novel coronavirus capable of lethal human infections: an emerging picture
n 216 Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full- length Spike protein of Middle East respiratory syndrome coronavirus
n 217 A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
n 218 An educational programme for nursing college staff and students during a MERS-coronavirus outbreak in Saudi Arabia
n 219 A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes
n 220 Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti- Coronavirus Drug Design OPEN
n 221 Molecular characterization of human coronaviruses and their circulation dynamics in Kenya
n 222 The history and epidemiology of Middle East respiratory syndrome corona virus
n 223 Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice
n 224 Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein
n 225 Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus?
n 226 Development of a Whole-Virus ELISA for Serological Evaluation of Domestic Livestock as Possible Hosts of Human Coronavirus NL63
n 227 Canine Respiratory Coronavirus, Bovine Coronavirus, and Human Coronavirus OC43: Receptors and Attachment Factors
n 228 Pathogenicity and Viral shedding of Mers-coV in immunocompromised rhesus Macaques
n 229 Dissecting Virus Entry: Replication-Independent Analysis of Virus Binding, Internalization, and Penetration Using Minimal Complementation of b-Galactosidase
n 230 What we are watching*five top global infectious disease threats, 2012: a perspective from CDC's Global Disease Detection Operations Center
n 231 Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study
n 232 Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
n 233 Epidemiology and Infection Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review
n 234 Isolation and genetic characterization of human coronavirus NL63 in primary human renal proximal tubular epithelial cells obtained from a commercial supplier, and confirmation of its replication in two different types of human primary kidney cells
n 235 Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus
n 236 Global epidemiology of avian influenza A(H5N1) virus infection in humans, 1997 -2015: a systematic review HHS Public Access
n 237 Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases
n 238 Case Report First Confirmed Case of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Bahrain: In a Saudi Gentleman after Cardiac Bypass Surgery
n 239 Article 1510 (2017) Establishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF
n 240 A pneumonia outbreak associated with a new coronavirus of probable bat origin
n 241 Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus
n 242 Antibodies and vaccines against Middle East respiratory syndrome coronavirus
n 243 Viral metagenomic analysis of feces of wild small carnivores
n 244 Viral Long-Term Evolutionary Strategies Favor Stability over Proliferation
n 245 Coronavirus Susceptibility to the Antiviral Remdesivir (GS- 5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
n 246 CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice
n 247 Coronaviruses and the human airway: a universal system for virus-host interaction studies
n 248 The CD8 T Cell Response to Respiratory virus infections
n 249 R A P I D C O M M U N I C A T I O N Middle East Respiratory Syndrome Coronavirus Antibody Reactors Among Camels in Dubai, United Arab Emirates, in 2005
n 250 Citation: One-Pot Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) for Detecting MERS-CoV
n 251 In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection
n 252 viruses Drivers of MERS-CoV Emergence in Qatar
n 253 A general strategy to inhibiting viral −1 frameshifting based on upstream attenuation duplex formation
n 254 The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015
n 255 The Nucleocapsid Protein of Human Coronavirus NL63
n 256 What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?
n 257 Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV)
n 258 Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
n 259 More Novel Hantaviruses and Diversifying Reservoir Hosts - Time for Development of Reservoir-Derived Cell Culture Models?
n 260 Efficient and unbiased metagenomic recovery of RNA virus genomes from human plasma samples OPEN
n 261 The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
n 262 The PDZ-Binding Motif of Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Is a Determinant of Viral Pathogenesis
n 263 Pandemic influenza viruses: time to recognize our inability to predict the unpredictable and stop dangerous gain-of-function experiments
n 264 Enterovirus D68 Infections Associated with Severe Respiratory Illness in Elderly Patients and Emergence of a Novel Clade in Hong Kong
n 265 Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
n 266 Identification of New Respiratory Viruses in the New Millennium
n 267 Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
n 268 Origins and pathogenesis of Middle East respiratory syndrome-associated coronavirus: recent advances [version 1; referees: 3 approved]
n 269 Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
n 270 Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity
n 271 Travel-related MERS-CoV cases: an assessment of exposures and risk factors in a group of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014
n 272 Potential Factors Influencing Repeated SARS Outbreaks in China
n 273 Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians
n 274 infection prevention Measures for Surgical procedures during a Middle east Respiratory Syndrome outbreak in a tertiary care Hospital in South Korea
n 275 A viral metagenomic survey identifies known and novel mammalian viruses in bats from Saudi Arabia
n 276 Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV)
n 277 The predictors of 3-and 30-day mortality in 660 MERS-CoV patients
n 278 Human Coronaviruses Associated with Upper Respiratory Tract Infections in Three Rural Areas of Ghana
n 279 Therapeutics and Vaccines
n 280 Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis
n 281 Field pathogenomics reveals the emergence of a diverse wheat yellow rust population
n 282 High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia
n 283 Rapid detection of MERS coronavirus-like viruses in bats: potential for tracking MERS coronavirus transmission and animal origin
n 284 APOBEC3-mediated restriction of RNA virus replication OPEN
n 285 Genetic drift of human coronavirus OC43 spike gene during adaptive evolution OPEN
n 286 Genome-wide analysis of codon usage bias in Bovine Coronavirus
n 287 Pretravel Considerations for Non-vaccine-Preventable Travel Infections
n 288 The prevalence of Middle East respiratory Syndrome coronavirus (MERS-CoV) infection in livestock and temporal relation to locations and seasons
n 289 Neue und seltene pneumotrope Viren
n 290 Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia
n 291 Health Care-Acquired Viral Respiratory Diseases
n 292 Prediction and prevention of the next pandemic zoonosis
n 293 Spread of MERS to South Korea and China
n 294 Protein Cell & Protein Cell & The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
n 295 Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases
n 296 Viral Diseases
n 297 King Abdulaziz Medical City, Ministry of National Guard Health Affairs
n 298 A multi-faceted approach of a nursing led education in response to MERS-CoV infection ଝ
n 299 Ferret models of viral pathogenesis
n 300 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
n 301 Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
n 302 Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins
n 303 Emerging Respiratory Viruses in Children
n 304 Reprint of: Coronavirus reverse genetic systems: Infectious clones and replicons ଝ
n 305 Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014
n 306 Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein
n 307 Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
n 308 Articles 694 www
n 309 Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
n 310 Loeffler 4.0: Diagnostic Metagenomics
n 311 Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential
n 312 Virus characterization and discovery in formalin-fixed paraffin-embedded tissues
n 313 Bats and their virome: an important source of emerging viruses capable of infecting humans
n 314 Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model
n 315 Coronaviruses: Molecular Biology ☆
n 316 Analytical performance of the automated multianalyte point-of-care mariPOC® for the detection of respiratory viruses
n 317 Critically ill patients with Middle East respiratory syndrome coronavirus infection
n 318 REVIEW Recent progress in the discovery of inhibitors targeting coronavirus proteases
n 319 DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
n 320 Articles Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
n 321 To sense or not to sense viral RNA -essentials of coronavirus innate immune evasion
n 322 Epidemiology of Viral Pneumonia
n 323 Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft Xing-Yi Ge
n 324 Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know
n 325 Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel
n 326 Current Opinion in Virology
n 327 Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments-The importance of immunofocusing in subunit vaccine design
n 328 Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein
n 329 Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus
n 330 Adaptive Evolution of MERS-CoV to Species Variation in DPP4 Adaptive Evolution of MERS-CoV to Species Variation in DPP4
n 331 El coronavirus causante del síndrome respiratorio de Oriente Medio The Middle East respiratory syndrome coronavirus
n 332 REVIEW A molecular arms race between host innate antiviral response and emerging human coronaviruses
n 333 Performance and clinical validation of the RealStar ® MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA
n 334 Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) Infection CASE PRESENTATION
n 335 MERS-CoV spike protein: Targets for vaccines and therapeutics
n 336 Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn?
n 337 MERS-CoV spike protein: a key target for antivirals HHS Public Access
n 338 Arch-shaped multiple-target sensing for rapid diagnosis and identification of emerging infectious pathogens
n 339 Growth and Quantification of MERS-CoV Infection
n 340 Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia
n 341 Supersize me: how whole-genome sequencing and big data are transforming epidemiology
n 342 Middle East respiratory syndrome coronavirus: quantifi cation of the extent of the epidemic, surveillance biases, and transmissibility
n 343 Articles Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
n 344 ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
n 345 Update on Emerging Infections: News From the Centers for Disease Control and Prevention
n 346 CARDIOVASCULAR, PULMONARY, AND RENAL PATHOLOGY Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract Implications for the Middle East Respiratory Syndrome
n 347 Leading Edge Review Reservoir Host Immune Responses to Emerging Zoonotic Viruses
n 348 Migrating a lab-developed MERS-CoV real-time PCR to 3 "Sample to Result" systems: experiences on optimization and validation
n 349 Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis
n 350 Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
n 351 MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
n 352 Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi
n 353 MERS: emergence of a novel human coronavirus
n 354 Outbreak of Middle East Respiratory Syndrome-Coronavirus Causes High Fatality After Cardiac Operations
n 355 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
n 356 M E D I C I N E The Role of Multiplex PCR in Respiratory Tract Infections in Children
n 357 Combination of IMODä and Arbidol to increase their immunomodulatory effects as a novel medicine to prevent and cure influenza and some other infectious diseases Journal of Medical Hypotheses and Ideas
n 358 Middle East Respiratory Syndrome-coronavirus infection: An overview
n 359 An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity
n 360 Development and validation of different indirect ELISAs for MERS-CoV serological testing
n 361 Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014
n 362 Serological assays for emerging coronaviruses: Challenges and pitfalls
n 363 Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model
n 364 Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
n 365 Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia
n 366 Influenza and Viral Pneumonia
n 367 Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
n 368 Severe pneumonia due to infection with Candida krusei in a case of suspected Middle East respiratory syndrome: A case report and literature review
n 369 Revista Clínica Española Características de las infecciones respiratorias agudas causadas por los coronavirus OC43, NL63 y 229E
n 370 Surveillance of upper respiratory infections using a new multiplex PCR assay compared to conventional methods during the influenza season in Taiwan
n 371 Human Respiratory Viruses ☆
n 372 Series Emerging respiratory tract infections 1 Surveillance for emerging respiratory viruses
n 373 BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface
n 374 and Health Professions, King Saud Bin Abdulaziz University for Health Sciences
n 375 Middle East Respiratory Syndrome -need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa
n 376 NMR structures and localization of the potential fusion peptides and the pre-transmembrane region of SARS-CoV: Implications in membrane fusion
n 377 SECTION B Viruses PART III Etiologic Agents of Infectious Diseases 222 Human Coronaviruses
n 378 Vaccines for the prevention against the threat of MERS-CoV
n 379 To assess the temporal dynamics of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in dromedary camels, specimens were collected at 1-2 month intervals from 2 independent groups of animals during MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014
n 380 Characterization of novel monoclonal antibodies against the MERS- coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA
n 381 The Middle East respiratory syndrome coronavirus ଝ El coronavirus causante del síndrome respiratorio de Oriente Medio
n 382 Health Care Worker Contact with MERS Patient, Saudi Arabia
n 383 The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015
n 384 Applying lessons from SARS to a newly identifi ed coronavirus
n 385 Unusual presentation of Middle East respiratory syndrome coronavirus leading to a large outbreak in Riyadh during 2017
n 386 Saudi Arabia Yaseen M Arabi, Department of Critical Care
n 387 Genotype shift in human coronavirus OC43 and emergence of a novel genotype by natural recombination
n 388 Clinical implication of radiographic scores in acute Middle East respiratory syndrome coronavirus pneumonia: Report from a single tertiary-referral center of South Korea
n 389 Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event
n 390 Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression
n 391 MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels
n 392 Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity
n 393 Middle East respiratory syndrome (MERS) coronavirus and dromedaries
n 394 Spike proteins of novel MERS-coronavirus isolates from North-and West- African dromedary camels mediate robust viral entry into human target cells
n 395 MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
n 396 Dynamics of scientific publications on the MERS-CoV outbreaks in Saudi Arabia
n 397 Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus
n 398 Emerging and Reemerging Infectious Disease Threats Chapter 14 Emerging and Reemerging Infectious Disease Threats
n 399 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015 Korea Centers for Disease Control and Prevention*
n 400 The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
n 401 DNA Vaccine Encoding Middle East Respiratory Syndrome Coronavirus S1 Protein Induces Protective Immune Responses in Mice HHS Public Access
n 402 Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
n 403 A R T I C L E I N F O
n 404 Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine type I non-structural ORF3 gene
n 405 Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/)
n 406 Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
n 407 A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case
n 408 Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections e
n 409 Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: Hide, mask, hit
n 410 SARS-CoV ORF1b-encoded nonstructural proteins 12-16: Replicative enzymes as antiviral targets
n 411 Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs
n 412 JIPH-1244; No. of Pages 5
n 413 Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
n 414 Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
n 415 Viral Pneumonia and Acute Respiratory Distress Syndrome
n 416 Viruses in bats and potential spillover to animals and humans
n 417 Public response to MERS-CoV in the Middle East: iPhone survey in six countries
n 418 Alisporivir inhibits MERS-and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model
n 419 The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future
n 420 Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature
n 421 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
n 422 Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
n 423 Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes A R T I C L E I N F O Keywords: MERS-and SARS-CoV Papain-like protease Disulfiram 6-Thioguanine Mycophenolic acid Synergistic inhibition
n 424 Outbreak of Middle East respiratory syndrome coronavirus, Saudi Arabian experience
n 425 Membrane ectopeptidases targeted by human coronaviruses
n 426 Acquisition of new protein domains by coronaviruses: analysis of overlapping genes coding for proteins N and 9b in SARS coronavirus
n 427 Synthesizing data and models for the spread of MERS-CoV, 2013: Key role of index cases and hospital transmission
n 428 Zoonoses 3 Prediction and prevention of the next pandemic zoonosis
n 429 Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent non-covalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease NIH Public Access
n 430 Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines NIH Public Access Author Manuscript
n 431 Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV)
n 432 Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients Egyptian Journal of Chest Diseases and Tuberculosis
n 433 MERS-CoV vaccine candidates in development: The current landscape
n 434 Moon
n 435 Interferon-α2b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques HHS Public Access Author manuscript
n 436 MERS coronavirus: Data gaps for laboratory preparedness
n 437 Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients
n 438 Middle East respiratory syndrome coronavirus (MERS-CoV): Prevention in travelers
n 439 What can we predict about viral evolution and emergence?
n 440 Intervention strategies for emerging viruses: use of antivirals
n 441 Novel SARS-like Betacoronaviruses in Bats, China, 2011
n 442 Saudi Arabia c Makkah Regional Health Affairs, Ministry of Health, Makkah, Kingdom of Saudi Arabia d National Health Laboratory, Ministry of Health
n 443 Evolution of SARS Coronavirus and the Relevance of Modern Molecular Epidemiology 26
n 444 Animal models for highly pathogenic emerging viruses
n 445 The OC43 human coronavirus envelope protein is critical for infectious virus production and propagation in neuronal cells and is a determinant of neurovirulence and CNS pathology
n 446 REACTing: the French response to infectious disease crises
n 447 NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion
n 448 Rapid and Effective Virucidal Activity of Povidone- Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA) Introduction: Since the first case of Middle East Respiratory Syndrome coronavirus (MERS-CoV)
n 449 Metagenomics for pathogen detection in public health
n 450 ARTICLE Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
n 451 Characterization of the interaction between recombinant porcine aminopeptidase N and spike glycoprotein of porcine epidemic diarrhea virus
n 452 External quality assessment for the molecular detection of MERS-CoV in China
n 453 Middle East respiratory syndrome coronavirus: Implications for health care facilities
n 454 Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
n 455 Isolation of MERS Coronavirus from Dromedary Camel, Qatar, 2014
n 456 Middle East Respiratory Syndrome Coronavirus Transmission
n 457 First international external quality assessment of molecular diagnostics for Mers-CoV
n 458 of Saudi Arabia; 4 Ministry of Health
n 459 Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
n 460 Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
n 461 Pneumonia from Human Coronavirus in a Macaque Model NIH Public Access NIH-PA Author Manuscript
n 462 "It feels like I'm the dirtiest person in the world." Exploring the experiences of healthcare providers who survived MERS-CoV in Saudi Arabia-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). Background
n 463 Coronavirus Disease 2019: Coronaviruses and Blood Safety
n 464 Engineering Infectious cDNAs of Coronavirus as Bacterial Artificial Chromosomes
n 465 Der Internist Coronaviren als Ursache respiratorischer Infektionen
n 466 Comment 942 www
n 467 Lectins from red algae and their biomedical potential
n 468 Middle East Respiratory Syndrome Coronavirus ''MERS-CoV'': Current Knowledge Gaps
n 469 Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species
n 470 Seminar Middle East respiratory syndrome
n 471 Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture
n 472 Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
n 473 THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS RESPIRATORY INFECTION: AN EMERGING INFECTION FROM THE ARABIAN PENINSULA
n 474 MERS: Progress on the global response, remaining challenges and the way forward FAO-OIE-WHO MERS Technical Working Group
n 475 Clinical imaging research of the first Middle East respiratory syndrome in China-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 476 Articles 1916 www
n 477 Coronavirus nonstructural protein 1: common and distinct functions in the regulation of host and viral gene expression HHS Public Access
n 478 Journal Pre-proof The SARS-CoV-2 outbreak: what we know The SARS-CoV-2 Outbreak: What We Know
n 479 Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
n 480 Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS- CoV Spike Glycoprotein Data and Software Availability 5ZXV 5YY5 Article Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
n 481 Clinical Usefulness PCR testing for Paediatric Acute Respiratory Tract Infections
n 482 Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method
n 483 Hazard Management, WHO Health Emergencies Programme, World Health Organization
n 484 Convalescent Plasma Immunotherapy for MERS-CoV
n 485 Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses
n 486 Middle East respiratory syndrome vaccines
n 487 Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
n 488 The Middle East Respiratory Syndrome (MERS)
n 489 Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
n 490 Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase
n 491 Large-scale machine learning of media outlets for understanding public reactions to nation-wide viral infection outbreaks
n 492 Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014
n 493 CORONAVIRUS REVERSE GENETIC SYSTEMS: INFECTIOUS CLONES AND REPLICONS
n 494 Structure, Function, and Evolution of Coronavirus Spike Proteins
n 495 A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples
n 496 Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice Article Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
n 497 Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome
n 498 The Middle East Respiratory Syndrome Coronavirus: An Emerging Virus of Global Threat
n 499 Influenza and other emerging respiratory viruses
n 500 Mass gathering medicine (Hajj Pilgrimage in Saudi Arabia): The clinical pattern of pneumonia among pilgrims during Hajj
n 501 Infection control influence of Middle East respiratory syndrome coronavirus: A hospital-based analysis
n 502 Saudi Arabia
n 503 Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
n 504 Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
n 505 Coronavirus and Other Respiratory Illnesses Comparing Older with Young Adults
n 506 Human Betacoronavirus 2c EMC/2012- related Viruses in Bats, Ghana and Europe
n 507 A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
n 508 Emerging viral diseases of livestock in the developing world
n 509 Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication
n 510 MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
n 511 Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
n 512 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
n 513 Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction
n 514 ScienceDirect Public health impact of disease-behavior dynamics Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et al
n 515 Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract Implications for the Middle East Respiratory Syndrome
n 516 MERS-CoV diagnosis: An update
n 517 Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015
n 518 The emerging novel Middle East respiratory syndrome coronavirus: The "knowns" and "unknowns"
n 519 Main factors influencing recovery in MERS Co-V patients using machine learning
n 520 Rapid detection of viral antibodies based on multifunctional Staphylococcus aureus nanobioprobes
n 521 Respiratory viral infections
n 522 Guide to Understanding the 2019 Novel Coronavirus
n 523 Stability of infectious human coronavirus NL63
n 524 Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond
n 525 Highlights from ProMED (www.promedmail.org) Latest outbreak news from ProMED-mail Novel coronavirus -Middle East §
n 526 Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study
n 527 Epidemiological investigation of Middle East respiratory syndrome coronavirus in dromedary camel farms linked with human infection in Abu Dhabi Emirate, United Arab Emirates
n 528 Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity
n 529 Viral abundance and its public health implications Editorial overview Marion Koopmans
n 530 Receptor-binding domain-based subunit vaccines against MERS-CoV
n 531 Geographic Distribution of MERS Coronavirus among Dromedary Camels, Africa
n 532 Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design
n 533 Antiviral Drugs Specific for Coronaviruses in Preclinical Development
n 534 EID podcast Tuberculosis Surveillance and Control in Puerto Rico
n 535 Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination
n 536 Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
n 537 Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
n 538 Follow-up of Contacts of Middle East Respiratory Syndrome Coronavirus-Infected Returning Travelers, the Netherlands, 2014
n 539 Evaluation of Patients under Investigation for MERS-CoV Infection, United States, DISPATCHES EID Podcast: Carbapenem-Resistant Enterobacteriaceae
n 540 Editorial overview: Emerging viruses
n 541 The use of multiplex PCR for the diagnosis of viral severe acute respiratory infection in children: a high rate of co-detection during the winter season
n 542 MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study
n 543 IMMUNOPATHOLOGY AND INFECTIOUS DISEASES An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity
n 544 New episode of Middle East Respiratory Syndrome Coronavirus outbreak in Saudi Arabia: an emerging public health threat
n 545 Archives of Psychiatric Nursing Mental Health of Nurses Working at a Government-designated Hospital During a MERS-CoV Outbreak: A Cross-sectional Study
n 546 Materials and Methods Clinical Setting
n 547 Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination q
n 548 Factors determining human-to-human transmissibility of zoonotic pathogens via contact This review comes from a themed issue on Emerging viruses: intraspecies transmission Edited by
n 549 Environmental sampling for respiratory pathogens in Jeddah airport during the 2013 Hajj season
n 550 Clinical validation of 3 commercial real-time reverse transcriptase polymerase chain reaction assays for the detection of Middle East respiratory syndrome coronavirus from upper respiratory tract specimens
n 551 Retrospective Validation of a Metagenomic Sequencing Protocol for Combined Detection of RNA and DNA Viruses Using Respiratory Samples from Pediatric Patients
n 552 Hemodialysis-Associated Infections*
n 553 Hunting Viral Receptors Using Haploid Cells
n 554 Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses
n 555 Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
n 556 JIPH-1240
n 557 Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution
n 558 Emerging Respiratory Viruses Other than Influenza
n 559 Article Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
n 560 Respiratory Virus Vaccines
n 561 Commonly circulating human coronaviruses do not have a significant role in the etiology of gastrointestinal infections in hospitalized children
n 562 Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia
n 563 On the biased nucleotide composition of the human coronavirus RNA genome
n 564 Intervention strategies for emerging respiratory virus infections: policy and public health considerations
n 565 Middle East Respiratory Syndrome
n 566 Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014
n 567 Newly emerged porcine enteric alphacoronavirus in southern China: Identification, origin and evolutionary history analysis
n 568 Anesthetic Management of Patients with Suspected 2019 Novel Coronavirus Infection During Emergency Procedures Special Article Title: Anesthetic Management of Patients with Suspected 2019 Novel Coronavirus Infection During Emergency Procedures
n 569 ACE2 e From the renineangiotensin system to gut microbiota and malnutrition
n 570 MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract
n 571 MERS-CoV in a healthcare worker in Jeddah, Saudi Arabia: an index case investigation
n 572 Human coronavirus and severe acute respiratory infection in Southern Brazil
n 573 Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus
n 574 Coronavirus cis-Acting RNA Elements
n 575 Emerging respiratory viruses: is it 'much ado about nothing'? (Shakespeare)
n 576 Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections
n 577 Revista Clínica Española Clinico-epidemiological characteristics of acute respiratory infections by coronavirus OC43, NL63 and 229E ଝ PALABRAS CLAVE
n 578 Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
n 579 Spatiotemporal Interplay of Severe Acute Respiratory Syndrome Coronavirus and Respiratory Mucosal Cells Drives Viral Dissemination in Rhesus Macaques HHS Public Access
n 580 Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella
n 581 From SARS to MERS: evidence and speculation
n 582 Evaluation of a panel of antibodies for the immunohistochemical identification of immune cells in paraffin-embedded lymphoid tissues of new-and old-world camelids
n 583 Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents
n 584 Lancet mass gatherings medicine 1 Hajj: infectious disease surveillance and control
n 585 Biological HRPs in wastewater 3 Chapter outline
n 586 Protease inhibitors targeting coronavirus and filovirus entry
n 587 Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments -the importance of immunofocusing in subunit vaccine design NIH Public Access Author Manuscript
n 588 Saudi Arabia b King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia c King Fahad General Hospital
n 589 Bats as reservoirs of severe emerging infectious diseases
n 590 Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
n 591 Detection of MERS-CoV antigen on formalin-fixed paraffin-embedded nasal tissue of alpacas by immunohistochemistry using human monoclonal antibodies directed against different epitopes of the spike protein
n 592 Case Report Health Care Associated Middle East Respiratory Syndrome (MERS): A Case from Iran
n 593 First detection of equine coronavirus (ECoV) in Europe
n 594 MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA
n 595 The Amino Acids 736-761 of the MERS-CoV Spike Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents
n 596 Molecular dynamics of Middle East Respiratory Syndrome Coronavirus (MERS CoV) fusion heptad repeat trimers
n 597 Detecting the emergence of novel, zoonotic viruses pathogenic to humans
n 598 Hosts and Sources of Endemic Human Coronaviruses
n 599 JIPH-1216; No. of Pages 5
n 600 Article Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
n 601 Epidemiologic Principles EPIDEMIOLOGIC STUDY METHODS
n 602 MERS-CoV: the intermediate host identified?
n 603 Are Saudi medical students aware of middle east respiratory syndrome coronavirus during an outbreak?
n 604 NAADP-dependent Ca 2+ signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system
n 605 Antiviral drugs specific for coronaviruses in preclinical development
n 606 Middle East respiratory syndrome coronavirus in the last two years: Health care workers still at risk
n 607 The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic
n 608 Reliable typing of MERS-CoV variants with a small genome fragment
n 609 The structure and functions of coronavirus genomic 3 and 5 ends
n 610 Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)
n 611 ARTICLE IN PRESS G Model Genetic diversity of MERS-CoV spike protein gene in Saudi Arabia
n 612 ScienceDirect Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)
n 613 Virus-Receptor Interactions: The Key to Cellular Invasion
n 614 Conservation of nucleotide sequences for molecular diagnosis of Middle East respiratory syndrome coronavirus, 2015
n 615 Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
n 616 Detection of viromes of RNA viruses using the next generation sequencing libraries prepared by three methods
n 617 Coronavirus reverse genetic systems: Infectious clones and replicons
n 618 Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS- CoV) replication in a human in-vitro and ex-vivo culture model
n 619 Journal Pre-proof SARS-CoV-2: fear versus data SARS-CoV-2: fear versus data
n 620 Vaccines for Emerging Viral Diseases Chapter Outline
n 621 Other Viral Pneumonias Coronavirus, Respiratory Syncytial Virus, Adenovirus, Hantavirus
n 622 Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
n 623 Review of Non-bacterial Infections in Respiratory Medicine: Viral Pneumonia ଝ
n 624 Middle East Respiratory Syndrome: What Clinicians Need to Know
n 625 Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)
n 626 Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
n 627 Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd
n 628 The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production ☆
n 629 Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from Brazil
n 630 Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein
n 631 Travel implications of emerging coronaviruses: SARS and MERS-CoV
n 632 Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
n 633 Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
n 634 Dae
n 635 Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
n 636 Journal Pre-proof Understanding the emerging coronavirus: what it means for health security and infection prevention Understanding the emerging coronavirus: what it means for health security and infection prevention
n 637 Virus discovery: one step beyond
n 638 Review Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission
n 639 The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
n 640 Structural characterization of the HCoV-229E fusion core
n 641 The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family
n 642 Gene Therapy for Respiratory Viral Infections 282 CHAPTER 9: Gene Therapy for Respiratory Viral Infections
n 643 RNA structure analysis of alphacoronavirus terminal genome regions
n 644 Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
n 645 Extensive diversity of coronaviruses in bats from China
n 646 Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
n 647 Structure and Function of Viral Deubiquitinating Enzymes Viruses and the Ub System
n 648 A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
n 649 Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
n 650 MERS-CoV Infection in a Pregnant Woman in Korea
n 651 Molecular pathology of emerging coronavirus infections
n 652 Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015
n 653 Original Article Clinical Microbiology External Quality Assessment of MERS-CoV Molecular Diagnostics During the 2015 Korean Outbreak
n 654 Emerging Microbes and Infections (2012) 1, e35
n 655 A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus
n 656 Identification of a Gamma Interferon-Activated Inhibitor of Translation-Like RNA Motif at the 3= End of the Transmissible Gastroenteritis Coronavirus Genome Modulating Innate Immune Response
n 657 MERS-coronavirus: From discovery to intervention-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 658 Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
n 659 Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia
n 660 Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex
n 661 Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse- transcriptase polymerase chain reaction
n 662 Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge ☆-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 663 Metagenomic ventures into outer sequence space
n 664 Some One Health based control strategies for the Middle East respiratory syndrome coronavirus
n 665 Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 666 Estimation Of Direct Medical Costs Of Middle East Respiratory Syndrome Coronavirus Infection: A Single-Center Retrospective Chart Review Study
n 667 Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
n 668 Waterpipe smoking as a public health risk: Potential risk for transmission of MERS-CoV-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 669 Infection and Drug Resistance Dovepress Middle east respiratory syndrome coronavirus: epidemiology and disease control measures
n 670 STATE OF THE ART 1B-H3-01 Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections
n 671 Development of Dual TaqMan Based One-Step rRT-PCR Assay Panel for Rapid and Accurate Diagnostic Test of MERS-CoV: A Novel Human Coronavirus, Ahead of Hajj Pilgrimage
n 672 Evaluation of visual triage for screening of Middle East respiratory syndrome coronavirus patients
n 673 Complex structure of MERS-CoV RBD with DPP4 986 Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
n 674 What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review
n 675 Investigation of an experimental infection model of equine coronavirus in adult horses
n 676 Editorial Commentary
n 677 Treatment strategies for Middle East respiratory syndrome coronavirus
n 678 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Oman: Current Situation and Going Forward
n 679 Lack of detection of Middle East respiratory syndrome coronavirus in mild and severe respiratory infections in Catalonia, northeastern Spain
n 680 Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia, 2015
n 681 Systemic resilience to cross-border infectious disease threat events in Europe
n 682 Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses
n 683 Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea
n 684 Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study
n 685 Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
n 686 Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study
n 687 Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia
n 688 Coronaviruses induce entry-independent, continuous macropinocytosis
n 689 SEARCH STRATEGY PubMed databases were searched for studies on MERS cases during the 2015 outbreak in the Republic of Korea. The search terms used were combinations of 'Middle East respiratory syndrome' in all fields and 'Korea' in all
n 690 Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
n 691 Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
n 692 Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015
n 693 The outbreak of COVID-19: An overview
n 694 Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
n 695 Journal Pre-proof Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
n 696 Knowledge, attitude and practice of secondary schools and university students toward Middle East Respiratory Syndrome epidemic in Saudi Arabia: A cross-sectional study Production and hosting by Elsevier-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 697 Periodic global One Health threats update-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 698 Inhibition of novel b coronavirus replication by a combination of interferon-a2b and ribavirin
n 699 Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
n 700 The Emergence of Human Coronavirus EMC: How Scared Should We Be?
n 701 Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus ‫هو‬ ‫أوسطية‬ ‫الشرق‬ ‫التنفسية‬ ‫للمتالزمة‬ ‫املسبب‬ ‫الكرونا‬ ‫فيروس‬ ‫إن‬ ‫من‬ ‫الريبوزي‬ ‫النووي‬ ‫احلمض‬ ‫فيروس‬ ‫نوع‬ ‫من‬ ‫أحادي‬ ‫نطاق‬ ‫ذو‬ ‫فيروس‬ ‫بسبب‬ ‫توفيت‬ ‫مريضه‬ ‫في‬ ً ‫أوال‬ ‫عزله‬ ‫مت‬ ‫الكرونا.‬ ‫لفيروس‬ ‫بيتا‬ ‫النوع‬ ‫السعودية.‬ ‫العربية‬ ‫اململكة‬ ‫في‬ 2012 ‫يونيو‬ ‫في‬ ‫شديد‬ ‫تنفسي‬ ‫مرض‬ ‫وتعمل‬ ‫سنة‬ 42 ‫العمر‬ ‫من‬ ‫تبلغ‬ ‫ملريضة‬ ‫إعتيادية‬ ‫غير‬ ‫حالة‬ ‫عن‬ ‫نتحدث‬ ‫ملستشفانا‬ ‫التابعة‬ ‫املركزة‬ ‫العناية‬ ‫قسم‬ ‫إدخالها‬ ‫مت‬ ‫الصحي‬ ‫املجال‬ ‫في‬ ‫حيث‬ ‫والشديدة‬ ‫احلادة‬ ‫التنفسية‬ ‫العسرة‬ ‫متالزمة‬ ‫تشخيص‬ ‫حتت‬ ‫بدون‬ ‫عفوي‬ ‫نزيف‬ ‫مع‬ ‫التفه‬ ‫بالبوال‬ ‫اإلصابة‬ ‫أعراض‬ ‫لديها‬ ‫ظهرت‬ ‫لوزيات‬ ‫انفتاق‬ ‫مع‬ ‫الدماغية‬ ‫والبطينات‬ ‫الدماغ‬ ‫ضمن‬ ‫وواسع‬ ‫سبب‬ ‫املادة‬ ‫بإستخدام‬ ‫للدماغ‬ ‫احملوري‬ ‫الطبقي‬ ‫التصوير‬ ‫يكشف‬ ‫لم‬ ‫الدماغ.‬ ‫لم‬ ‫تشريحية.‬ ‫بنيوية‬ ‫عيوب‬ ‫أو‬ ‫دماغية‬ ‫دم‬ ‫ألم‬ ‫تواجد‬ ‫أي‬ ‫الظليلة‬ ‫في‬ ‫اعتالل‬ ‫أو‬ ‫مظبوط‬ ‫غير‬ ‫الضغط‬ ‫في‬ ‫إرتفاع‬ ‫بأي‬ ‫اصيبت‬ ‫أن‬ ‫يحدث‬ ‫من‬ ‫نادرة‬ ‫احلالة‬ ‫هذه‬ ‫صفيحات.‬ ‫مضاد‬ ‫عطيت‬ ُ ‫أ‬ ‫أنها‬ ‫حتى‬ ‫أو‬ ‫الدم‬ ‫تخثر‬ ‫بفيروس‬ ‫اإللتهابية‬ ‫اإلصابة‬ ‫مع‬ ‫العصبي‬ ‫الضرر‬ ‫تالزم‬ ‫على‬ ‫تدلل‬ ‫نوعها‬ ‫أوسطية.‬ ‫الشرق‬ ‫التنفسية‬ ‫للمتالزمة‬ ‫املسبب‬ ‫الكرونا‬
n 702 Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus
n 703 A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant
n 704 Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
n 705 The Middle East Respiratory Syndrome-How Worried Should We Be? A NOVEL VIRUS IS IDENTIFIED IN SAUDI ARABIA
n 706 Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential
n 707 A Scenario-Based Evaluation of the Middle East Respiratory Syndrome Coronavirus and the Hajj
n 708 Detection of the Middle East Respiratory Syndrome Coronavirus Genome in an Air Sample Originating from a Camel Barn Owned by an Infected Patient
n 709 COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
n 710 Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection HHS Public Access
n 711 Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies HHS Public Access
n 712 LETTER TO THE EDITOR DIFFERENTIAL DIAGNOSIS OF RESPIRATORY VIRUSES BY USING REAL TIME RT-PCR METHODOLOGY
n 713 Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus
n 714 Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread
n 715 Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis
n 716 Major advances in managing community-acquired pneumonia
n 717 Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
n 718 Challenges presented by MERS corona virus, and SARS corona virus to global health
n 719 From the review MerS-coV
n 720 Global Infectious Hazards Management, Health Emergencies Program, World Health Organization
n 721 Co-localization of Middle East respiratory syndrome coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory tract and lymphoid tissues of pigs and llamas
n 722 Public preferences for interventions to prevent emerging infectious disease threats: a discrete choice experiment
n 723 Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
n 724 An updated roadmap for MERS-CoV research and product development: focus on diagnostics Analysis
n 725 A Case Report of a Middle East Respiratory Syndrome Survivor with Kidney Biopsy Results
n 726 Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
n 727 Global patterns in coronavirus diversity
n 728 Mechanisms of Severe Acute Respiratory Syndrome Coronavirus- Induced Acute Lung Injury
n 729 Middle East respiratory syndrome in children Dental considerations ‫الشرق‬ ‫كورونا‬ ‫لفيروس‬ ً ‫مختيريا‬ ‫مؤكدة‬ ‫عدوى‬ ‫حالة‬ 1,633 ‫هناك‬ ‫متعلقة‬ ‫وفاة‬ ‫حالة‬ 587 ‫عن‬ ‫العاملية‬ ‫الصحة‬ ‫منظمة‬ ‫اعلنت‬ ‫األوسط.‬ ‫قد‬ ‫أو‬ ‫فردي‬ ‫بشكل‬ ‫األوسط‬ ‫الشرق‬ ‫كورونا‬ ‫فيروس‬ ‫يحدث‬ ‫قد‬ ‫به.‬ ‫بني‬ ‫لتزايده‬ ‫موكدة‬ ‫حاالت‬ ‫وهناك‬ ‫املستشفيات‬ ‫أو‬ ‫األسر‬ ‫داخل‬ ‫ينتقل‬ ‫اجلوي‬ ‫الهباء‬ ‫طريق‬ ‫عن‬ ً ‫أيضا‬ ‫ينتشر‬ ‫قد‬ ‫الصحية،‬ ‫الرعاية‬ ‫في‬ ‫العاملني‬ ‫واملريض.‬ ‫األسنان‬ ‫طبيب‬ ‫بني‬ ‫النتقاله‬ ‫يؤدي‬ ‫مما‬ ‫األسنان‬ ‫عالج‬ ‫عند‬ ‫مما‬ ‫األطفال‬ ‫بني‬ ‫األوسط‬ ‫الشرق‬ ‫كورونا‬ ‫لفيروس‬ ‫علنه‬ ُ ‫م‬ ‫حاالت‬ ‫هناك‬ ‫هذا‬ ‫عدوى‬ ‫البحث‬ ‫هذا‬ ‫للخطر.يناقش‬ ‫األطفال‬ ‫أسنان‬ ‫أطباء‬ ‫يعرض‬ ‫وأطباء‬ ‫الصحية‬ ‫الرعاية‬ ‫مجال‬ ‫في‬ ‫والعاملني‬ ‫األطفال‬ ‫بني‬ ‫الفيروس‬ ‫عن‬ ‫اآلن‬ ‫حتى‬ ‫عن‬ ‫اإلبالغ‬ ‫يتم‬ ‫لم‬ ‫أنه‬ ‫الرغم‬ ‫على‬ ‫األطفال‬ ‫أسنان‬ ‫انتقال‬ ‫خطر‬ ‫يرتفع‬ ‫قد‬ ‫أسنان.‬ ‫وطبيب‬ ‫مريض‬ ‫بني‬ ‫النتقاله‬ ‫حاالت‬ ‫العمل‬ ‫بيئة‬ ‫بسبب‬ ‫مصاب‬ ‫مريض‬ ‫من‬ ‫اأوسط‬ ‫الشرق‬ ‫كورونا‬ ‫فيروس‬ ‫اجلوي)‬ ‫الهباء‬ ‫(توليد‬ ‫األسنان‬ ‫ألطباء‬ ‫الفريدة‬
n 730 The New Age of Virus Discovery: Genomic Analysis of a Novel Human Betacoronavirus Isolated from a Fatal Case of Pneumonia
n 731 Severe fever with thrombocytopenia syndrome virus expands its borders
n 732 Human Coronavirus-HKU1 Infection Among Adults in Cleveland, Ohio
n 733 Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE HHS Public Access
n 734 Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles
n 735 Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
n 736 Kingdom of Saudi Arabia e ; Saudi Aramco Medical Services Organization, Saudi Aramco, Dhahran, Kingdom of Saudi Arabia f ; Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia g
n 737 Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak
n 738 Silent War to Emerging or Re-emerging Respiratory Infection Diseases Badly Kept in Mind
n 739 Virus ecology: a gap between detection and prediction
n 740 Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
n 741 Middle East respiratory syndrome coronavirus in children ‫اجلديدة‬ ‫البشرية‬ ‫األمراض‬ ‫من‬ ‫التنفسية‬ ‫األوسط‬ ‫الشرق‬ ‫متالزمة‬ ‫تعد‬ ‫الفيروس‬ ‫هذا‬ ‫انتشر‬ ‫ولقد‬ ‫اجلديد.‬ ‫كورونا‬ ‫فيروس‬ ‫بها‬ ‫تسبب‬ ‫التي‬ ‫املعلومات‬ ‫كانت‬ ‫حني‬ ‫في‬ ‫املنشورة،‬ ‫التقارير‬ ‫حسب‬ ‫البالغني‬ ‫بني‬ ً ‫غالبا‬ ‫فيروس‬ ‫يظهر‬ ‫اآلن.‬ ‫حتى‬ ‫نادرة‬ ‫األطفال‬ ‫بني‬ ‫الفيروس‬ ‫هذا‬ ‫عن‬ ‫املنشورة‬ ‫أنه‬ ‫كما‬ ‫السريرية،‬ ‫املظاهر‬ ‫من‬ ‫كبيرة‬ ‫مبجموعة‬ ‫األطفال‬ ‫بني‬ ‫كورونا‬ ‫البالغني.‬ ‫بني‬ ‫عنها‬ ‫اإلبالغ‬ ‫مت‬ ‫التي‬ ‫تلك‬ ‫من‬ ‫أقل‬ ‫وفيات‬ ‫مبعدل‬ ‫مرتبط‬ ‫من‬ ‫يعانون‬ ‫الذين‬ ‫املرضى‬ ‫بني‬ ‫السيئة‬ ‫املرض‬ ‫نتائج‬ ‫ُالحظ‬ ‫ت‬ ‫ما‬ ً ‫وغالبا‬ ‫من‬ ‫يبلغ‬ ‫طفل‬ ‫حالة‬ ‫املقال‬ ‫هذا‬ ‫في‬ ‫نستعرض‬ ‫أخرى.‬ ‫صحية‬ ‫مشاكل‬ ‫أعراض‬ ‫إلى‬ ‫باإلضافة‬ ‫كورونا،‬ ‫بفيروس‬ ‫صيب‬ ُ ‫أ‬ ‫وقد‬ ‫أشهر،‬ 9 ‫العمر‬ ‫بالبحث‬ ‫قمنا‬ ‫لقد‬ ‫املوت.‬ ‫ثم‬ ‫ومن‬ ‫متعدد‬ ‫عضوي‬ ‫وفشل‬ ‫حادة‬ ‫تنفسية‬ ‫التي‬ ‫السريرية‬ ‫املظاهر‬ ‫وصف‬ ‫محاولة‬ ‫في‬ ‫وذلك‬ ‫العلمي‬ ‫األدب‬ ‫في‬ ‫بهذا‬ ‫اإلصابة‬ ‫خطر‬ ‫من‬ ‫تزيد‬ ‫التي‬ ‫والعوامل‬ ‫املرضى،‬ ‫هؤالء‬ ‫بها‬ ‫يظهر‬ ‫األطفال.‬ ‫بني‬ ‫املرض‬ ‫هذا‬ ‫ملثل‬ ‫املتوقعة‬ ‫النتائج‬ ‫وكذلك‬ ‫الفيروس،‬ Case Report
n 742 Num 2
n 743 Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus | RESEARCH REPORT
n 744 Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases
n 745 Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndrome
n 746 A novel method for synthetic vaccine construction based on protein assembly
n 747 National Science and Technology Major Project (No. 2017ZX10204401); National Natural Science Foundation of China
n 748 Identification of a novel coronavirus in patients with severe acute respiratory syndrome
n 749 Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group
n 750 Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2
n 751 Clinical characteristics of 82 death cases with COVID-19
n 752 Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study Summary Background
n 753 Comparative analysis of primer-probe sets for the laboratory confirmation of SARS-CoV-2
n 754 MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins
n 755 Virology Journal Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus
n 756 Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell Line A new report describes the isolation and characterization of a novel gammaherpesvirus from a microbat cell line crossmark
n 757 Interaction of severe acute respiratory syndrome- coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2
n 758 BMC Infectious Diseases A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection
n 759 Global research trends of World Health Organization's top eight emerging pathogens
n 760 Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
n 761 The Study of Viral RNA Diversity in Bird Samples Using De Novo Designed Multiplex Genus-Specific Primer Panels
n 762 Profiling of Substrate Specificity of SARS-CoV 3CL pro
n 763 Coronavirus Gene 7 Counteracts Host Defenses and Modulates Virus Virulence
n 764 Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction
n 765 Genetic Variation of the Human a-2-Heremans-Schmid Glycoprotein (AHSG) Gene Associated with the Risk of SARS-CoV Infection
n 766 A Fusion Peptide in the Spike Protein of MERS Coronavirus
n 767 Emerging Microbes & Infections (2017) 6, e14
n 768 SARS-CoV 9b Protein Diffuses into Nucleus, Undergoes Active Crm1 Mediated Nucleocytoplasmic Export and Triggers Apoptosis When Retained in the Nucleus
n 769 Virology Journal Identification of a contemporary human parechovirus type 1 by VIDISCA and characterisation of its full genome
n 770 viruses Exploiting the Legacy of the Arbovirus Hunters
n 771 Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNa Responses by Plasmacytoid Dendritic Cells
n 772 First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood
n 773 Characterization of a novel orthoreovirus isolated from fruit bat, China
n 774 Application of next-generation sequencing technologies in virology
n 775 Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells
n 776 The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor
n 777 The N-Terminal Domain of Spike Protein Is Not the Enteric Tropism Determinant for Transmissible Gastroenteritis Virus in Piglets
n 778 An Economical Tandem Multiplex Real-Time PCR Technique for the Detection of a Comprehensive Range of Respiratory Pathogens
n 779 The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
n 780 The Author(s) BMC Genomics
n 781 Bat Airway Epithelial Cells: A Novel Tool for the Study of Zoonotic Viruses
n 782 SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b
n 783 SARS: Systematic Review of Treatment Effects
n 784 Surface vimentin is critical for the cell entry of SARS-CoV
n 785 Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis
n 786 Reconstructed Ancestral Sequences Improve Pathogen Identification Using Resequencing DNA Microarrays
n 787 Virology Journal Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo
n 788 BMC Genomics Improved microarray gene expression profiling of virus-infected cells after removal of viral RNA
n 789 Seroepidemiology of Human Bocavirus Infection in Jamaica
n 790 Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis
n 791 Virology Journal Genome structure and transcriptional regulation of human coronavirus NL63
n 792 The Role of Severe Acute Respiratory Syndrome (SARS)-Coronavirus Accessory Proteins in Virus Pathogenesis
n 793 Emergence of MERS-CoV in the Middle East: Origins, Transmission, Treatment, and Perspectives
n 794 Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage
n 795 BMC Infectious Diseases A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium
n 796 Characterization of the Complete Genome of Chikungunya in Zhejiang, China, Using a Modified Virus Discovery Method Based on cDNA-AFLP
n 797 Solving the master equation for Indels
n 798 The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus
n 799 Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection
n 800 BMC Genomics Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV)
n 801 Virology Journal Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies
n 802 Respiratory Research Molecular mechanisms of severe acute respiratory syndrome (SARS)
n 803 European Bats as Carriers of Viruses with Zoonotic Potential
n 804 Tropical Medicine and Infectious Disease Policy and Science for Global Health Security: Shaping the Course of International Health
n 805 Virology Journal G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells
n 806 Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus
n 807 Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9
n 808 Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies
n 809 A Bat-Derived Putative Cross-Family Recombinant Coronavirus with a Reovirus Gene a11111 OPEN ACCESS
n 810 Differential stepwise evolution of SARS coronavirus functional proteins in different host species
n 811 Croup Is Associated with the Novel Coronavirus NL63
n 812 BMC Immunology Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
n 813 Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV
n 814 Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody
n 815 Characterization of Human Coronavirus Etiology in Chinese Adults with Acute Upper Respiratory Tract Infection by Real-Time RT-PCR Assays
n 816 Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS
n 817 Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome- Associated Coronavirus Infection
n 818 Viral etiology of acute respiratory infections in hospitalized children in Novosibirsk City, Russia (2013 -2017)
n 819 BMC Infectious Diseases Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection
n 820 Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections
n 821 Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys
n 822 Virology Journal Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein
n 823 The early immune response to infection of chickens with Infectious Bronchitis Virus (IBV) in susceptible and resistant birds
n 824 Prevalence and genetic diversity of coronaviruses in wild birds, Finland
n 825 Inhibition of RNA Helicases of ssRNA + Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae Families
n 826 New Vaccine Technologies to Combat Outbreak Situations
n 827 Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
n 828 Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions
n 829 Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
n 830 Analysis of Intraviral Protein-Protein Interactions of the SARS Coronavirus ORFeome
n 831 Identifying SARS-CoV Membrane Protein Amino Acid Residues Linked to Virus-Like Particle Assembly
n 832 BMC Microbiology Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups
n 833 A Family-Wide RT-PCR Assay for Detection of Paramyxoviruses and Application to a Large-Scale Surveillance Study
n 834 SARS Transmission Pattern in Singapore Reassessed by Viral Sequence Variation Analysis
n 835 The YXXΦ motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport
n 836 A Multigene Approach for Comparing Genealogy of Betacoronavirus from Cattle and Horses
n 837 BMC Immunology Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV
n 838 Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
n 839 Clinical Medicine Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China
n 840 Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
n 841 Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures
n 842 SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
n 843 A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses
n 844 Attenuation of replication by a 29 nucleotide deletion in SARS- coronavirus acquired during the early stages of human-to-human transmission OPEN
n 845 siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells
n 846 False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid-Based Western Blot Assay Were Rectified by the Use of Two Subunits (S1 and S2) of Spike for Detection of Antibody to SARS-CoV
n 847 DIRECTIVE CLINIQUE DE LA SOGC
n 848 Changement de tropisme des coronavirus
n 849 Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
n 850 Epidemiologic Clues to SARS Origin in China SARS Origin in China
n 851 Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening
n 852 Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
n 853 Use of Antibody Avidity Assays for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus Infection ᰔ
n 854 The SARS-Coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein
n 855 The ''SARS-unique domain'' (SUD) of SARS coronavirus is an oligo(G)-binding protein
n 856 Purified coronavirus Spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
n 857 Identification of a New Region of SARS-CoV S Protein Critical for Viral Entry
n 858 Reducing agents affect inhibitory activities of compounds: Results from Multiple Drug Targets
n 859 The Cell Biology of Acute Childhood Respiratory Disease: Therapeutic Implications
n 860 How much reduction of virus is needed for recycled water: A continuous changing need for assessment?
n 861 Techcenter at UMBC, 1450 South Rolling Road
n 862 Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
n 863 Susceptibility of different eukaryotic cell lines to SARS-coronavirus Brief Report
n 864 Expression cloning of functional receptor used by SARS coronavirus
n 865 The Clinical Presentation and Outcomes of Children Infected with Newly Identified Respiratory Tract Viruses
n 866 Structure of the SARS Coronavirus Nucleocapsid Protein RNA-binding Dimerization Domain Suggests a Mechanism for Helical Packaging of Viral RNA
n 867 Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease
n 868 SARS-associated Coronavirus Transmission, United States
n 869 Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein NIH Public Access
n 870 Adverse Effects of Ribavirin and Outcome in Severe Acute Respiratory Syndrome* Experience in Two Medical Centers
n 871 Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
n 872 Ribavirin and interferon-b synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
n 873 Immunological, structural, and preliminary X-ray diffraction characterizations of the fusion core of the SARS-coronavirus spike protein q
n 874 Molecular biology of severe acute respiratory syndrome coronavirus
n 875 CD8 + T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
n 876 Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain
n 877 Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion
n 878 Phylogenetic analysis and sequence comparisons of structural and non-structural SARS coronavirus proteins in Taiwan
n 879 FIGURE 3.4 Measurable impacts of enzootic and epizootic rabies and the "tip-of-the- iceberg" concept. RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT 2 globAl EPidEmiology 65 2 GLOBAL EPIDEMIOLOGY
n 880 Solution Structure of the C-terminal Dimerization Domain of SARS Coronavirus Nucleocapsid Protein Solved by the SAIL-NMR Method
n 881 Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
n 882 Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA
n 883 Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry
n 884 Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
n 885 Lessons from the Severe Acute Respiratory Syndrome Outbreak in Hong Kong
n 886 Simulating the SARS outbreak in Beijing with limited data
n 887 Prevalence and clinical characteristics of human CoV-HKU1 in children with acute respiratory tract infections in China
n 888 Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine
n 889 A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors
n 890 Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
n 891 Surrogate viruses for testing virucidal efficacy of chemical disinfectants
n 892 Antiviral Agents ☆
n 893 Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population
n 894 Confronting SARS: a view from Hong Kong
n 895 Tracking the Evolution of the SARS Coronavirus Using High-Throughput, High-Density Resequencing Arrays
n 896 Human coronavirus ocurrence in different populations of Sao Paulo: A comprehensive nine-year study using a pancoronavirus RT-PCR assay
n 897 Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein
n 898 Viral lung infections and the potential for a human pandemic
n 899 The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
n 900 Localisation and distribution of O-acetylated N-acetylneuraminic acids, the endogenous substrates of the hemagglutinin-esterases of murine coronaviruses, in mouse tissue
n 901 Emerging Infections and Pregnancy: West Nile Virus, Monkeypox, Severe Acute Respiratory Syndrome, and Bioterrorism
n 902 Identification of six new polymorphisms in the human coronavirus 229E receptor gene (aminopeptidase N/CD13) ଝ
n 903 SARS Coronavirus E Protein in Phospholipid Bilayers: An X-Ray Study
n 904 A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents
n 905 Psychosocial and coping responses within the community health care setting towards a national outbreak of an infectious disease
n 906 Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
n 907 SOGC CLINICAL PRACTICE GUIDELINE No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)
n 908 Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus
n 909 Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells
n 910 Cell adhesion as a novel approach to determining the cellular binding motif on the severe acute respiratory syndrome coronavirus spike protein
n 911 Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS
n 912 Long-term Effects of Providing Healthcare for SARS Emerging Infectious Diseases • www
n 913 Coordinate induction of IFN-a and -g by SARS-CoV also in the absence of virus replication
n 914 The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein
n 915 Comparisons of envelope through 5B sequences of infectious bronchitis coronaviruses indicates recombination occurs in the envelope and membrane genes
n 916 The dominance of human coronavirus OC43 and NL63 infections in infants
n 917 Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins ᰔ Downloaded from
n 918 Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model
n 919 The complete sequence of the bovine torovirus genome
n 920 Pathogenesis of Murine Coronavirus in the Central Nervous System
n 921 Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound ଝ
n 922 Differential virological diagnosis of acute respiratory infections in suspect SARS patients I. GROG Collective Name of the GROG Network: Groupes Régionaux d'Observation de la Grippe, France
n 923 Mice Susceptible to SARS Coronavirus
n 924 Paediatric emergency department staff perceptions of infection control measures against severe acute respiratory syndrome
n 925 Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
n 926 Cis-acting structural element in 5 UTR is essential for infectivity of porcine reproductive and respiratory syndrome virus
n 927 Production of Authentic SARS-CoV M pro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction
n 928 Expression, purification, and characterization of SARS coronavirus RNA polymerase
n 929 Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2 Infection
n 930 The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats
n 931 animal Models of Human Viral Diseases
n 932 The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase q
n 933 Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses
n 934 CORONAVIRUS E PROTEIN FORMS ION CHANNELS WITH FUNCTIONALLY AND STRUCTURALLY-INVOLVED MEMBRANE LIPIDS
n 935 A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
n 936 Mini-review Coronaviruses and their therapy
n 937 The use of Armored RNA as a multi-purpose internal control for RT-PCR
n 938 A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity
n 939 Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
n 940 Identification of encoding proteins related to SARS-CoV
n 941 High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery
n 942 Coronavirus phylogeny based on a geometric approach
n 943 Nursing care of patients with severe acute respiratory syndrome in the intensive care unit: case reports in Hong Kong
n 944 QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro )
n 945 Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
n 946 Host cell proteases: critical determinants of coronavirus tropism and pathogenesis
n 947 The 2003 SARS outbreak and its impact on infection control practices
n 948 Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children
n 949 Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
n 950 Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X- ray Structure and Biological Evaluation
n 951 Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
n 952 EMERGENCE OF SARS
n 953 Emerging infectious disease outbreaks: Old lessons and new challenges for obstetrician-gynecologists
n 954 RNAi therapeutics Can siRNAs conquer SARS?
n 955 Is there an ideal animal model for SARS?
n 956 Thrombopoietin levels increased in patients with severe acute respiratory syndrome
n 957 Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan
n 958 Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication
n 959 J A N U A R Y 2 0 0 4 4 3 : 1 A N N A L S O F E M E R G E N C Y M E D I C I N E 2 3 America' s Emergency Care System and Severe Acute Respiratory Syndrome: Are We Ready?
n 960 Colonization of Severe Acute Respiratory Syndrome-Associated Coronavirus Among Health-Care Workers Screened by Nasopharyngeal Swab*
n 961 Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus
n 962 Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics
n 963 Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: Insights on viral regulation of apoptosis and proliferation
n 964 The aetiology, origins, and diagnosis of severe acute respiratory syndrome
n 965 The design and application of DNA chips for early detection of SARS-CoV from clinical samples
n 966 Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
n 967 Virus respiratorios: viejos y nuevos virus. Revisión de métodos diagnósticos
n 968 Age-and gender-related difference of ACE2 expression in rat lung
n 969 Detection of coronavirus genomes in Moluccan naked-backed fruit bats in Indonesia
n 970 Human coronaviruses: Clinical features and phylogenetic analysis
n 971 Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China EMERGENCE OF SARS
n 972 Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A
n 973 Treatment of Severe Acute Respiratory Syndrome With Glucosteroids* The Guangzhou Experience
n 974 RNAi, a new therapeutic strategy against viral infection
n 975 Characterization of severe acute respiratory syndrome coronavirus membrane protein
n 976 Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein
n 977 OT Manifestations of Lung Changes and Complications in Patients with Severe Acute Respiratory .Syndrome
n 978 Four cases of severe acute respiratory syndrome (SARS) that occurred from
n 979 Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
n 980 Síndrome respiratorio agudo grave, gripe aviar e infección por metapneumovirus humano
n 981 Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression
n 982 Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
n 983 Severe Acute Respiratory Syndrome-associated Coronavirus Infection
n 984 SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era
n 985 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
n 986 The severe acute respiratory syndrome epidemic in mainland China dissected
n 987 Novel Immunofluorescence Assay Using Recombinant Nucleocapsid-Spike Fusion Protein as Antigen To Detect Antibodies against Severe Acute Respiratory Syndrome Coronavirus
n 988 The rationale of fever surveillance to identify patients with severe acute respiratory syndrome in Taiwan
n 989 The substrate specificity of SARS coronavirus 3C-like proteinase
n 990 Coronavirus in severe acute respiratory syndrome (SARS) Severe acute respiratory syndrome: identification of the etiological agent
n 991 Characterization of N protein self-association in coronavirus ribonucleoprotein complexes
n 992 Detection of SARS Coronavirus in Patients with Suspected SARS EMERGENCE OF SARS
n 993 Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody ᰔ
n 994 Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide Epoxide
n 995 Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines
n 996 Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
n 997 Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
n 998 Seroepidemiology of group I human coronaviruses in children
n 999 INFECTIOUS DISEASES OF THE LUNGS 32 VIRAL INFECTIONS
n 1000 Emerging respiratory agents: New viruses for old diseases?
n 1001 Laboratory diagnosis of viral infection
n 1002 Clinical Applications of Quantitative Real-Time PCR in Virology 5
n 1003 Modelling strategies for controlling SARS outbreaks
n 1004 SARS Coronavirus Detection
n 1005 Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development
n 1006 Clinical Trials and Novel Pathogens: Lessons Learned from SARS
n 1007 Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV
n 1008 Journal homepag g Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication
n 1009 Molecular diagnostics in virology
n 1010 Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients
n 1011 Structurally-and dynamically-driven allostery of the chymotrypsin- like proteases of SARS, Dengue and Zika viruses
n 1012 SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation
n 1013 Distant Relatives of Severe Acute Respiratory Syndrome Coronavirus and Close Relatives of Human Coronavirus 229E in Bats, Ghana
n 1014 A review of studies on animal reservoirs of the SARS coronavirus
n 1015 Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids
n 1016 Correlation of High-Resolution CT, Symptoms, and Pulmonary Function in Patients During Recovery From Severe Acute Respiratory Syndrome*
n 1017 Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV)
n 1018 Life-Threatening Viral Disease and Its Treatment
n 1019 Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction
n 1020 Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection
n 1021 Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases
n 1022 Combining Clinical and Epidemiologic Features for Early Recognition of SARS PERSPECTIVE CLINICAL STUDIES
n 1023 Large-scale sequencing and the natural history of model human RNA viruses NIH Public Access Author Manuscript Large-scale molecular epidemiology of emerging & circulating RNA viruses
n 1024 LightUp Ò probes in clinical diagnostics
n 1025 Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods
n 1026 Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay
n 1027 Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
n 1028 Bayesian Modelling of an Epidemic of Severe Acute Respiratory Syndrome
n 1029 SARS safety and science
n 1030 Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus
n 1031 Interferon and cytokine responses to SARS-coronavirus infection
n 1032 Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus
n 1033 The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines
n 1034 Many severe acute respiratory syndrome (SARS) patients have multiple possible incubation periods due to multiple contact dates. Multiple contact dates cannot be used in standard statistical analytic techniques, however. I present a simple spreadsheet-based method that uses multiple contact dates to calculate the possible incubation periods of SARS. DISPATCH SARS EPIDEMIOLOGY
n 1035 Induction of Specific Immune Responses by Severe Acute Respiratory Syndrome Coronavirus Spike DNA Vaccine with or without Interleukin-2 Immunization Using Different Vaccination Routes in Mice ᰔ
n 1036 Possible SARS Coronavirus Transmission during Cardiopulmonary Resuscitation
n 1037 The intracellular sites of early replication and budding of SARS-coronavirus
n 1038 Fund from Chinese Ministry of Education, National Basic Research Program of China (2003CB 514107) and Guangdong Provincial Fund of SARS
n 1039 International Association of National Public Health Institutes (IANPHI), Emory Global Health Institute
n 1040 Genomic characterization of equine coronavirus
n 1041 Segmentation of DNA using simple recurrent neural network
n 1042 Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
n 1043 Subcellular localization and membrane association of SARS-CoV 3a protein
n 1044 Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase
n 1045 Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
n 1046 Human Metapneumovirus Detection in Patients with Severe Acute Respiratory Syndrome
n 1047 Distinctive clinical features of human bocavirus in children younger than 2 years
n 1048 Development of antiviral therapy for severe acute respiratory syndrome
n 1049 Severe Acute Respiratory Syndrome Historical, Epidemiologic, and Clinical Features
n 1050 A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses
n 1051 Structural insights into SARS coronavirus proteins
n 1052 Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
n 1053 Severe Acute Respiratory Syndrome (SARS) GEOGRAPHIC DISTRIBUTION AND MAGNITUDE OF DISEASE BURDEN Background
n 1054 Immunofluorescence Assay for Serologic Diagnosis of SARS
n 1055 Neumonía asiática/síndrome respiratorio agudo severo. Epidemia en un mundo globalizado
n 1056 Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers
n 1057 Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture
n 1058 Detection of human coronaviruses in children with acute gastroenteritis
n 1059 The largest outbreak of severe acute respiratory syn- drome (SARS) struck Beijing in spring 2003. Multiple importations of SARS to
n 1060 Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan 1
n 1061 Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines
n 1062 The aetiology of SARS: Koch's postulates fulfilled
n 1063 Molecular Testing in Emerging Infectious Diseases BACKGROUND AND CATALOGUE OF EMERGING INFECTIOUS AGENTS
n 1064 Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques
n 1065 Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers
n 1066 Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies
n 1067 Detection of pancoronavirus using PCR in Camelus dromedarius in Iran (first report)
n 1068 Original Article An Improved Barcoded Oligonucleotide Primers-based Next-generation Sequencing Approach for Direct Identification of Viral Pathogens in Clinical Specimens *
n 1069 Burden of disease due to human coronavirus NL63 infections and periodicity of infection
n 1070 Effectiveness of Noninvasive Positive Pressure Ventilation in the Treatment of Acute Respiratory Failure in Severe Acute Respiratory Syndrome*
n 1071 SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion
n 1072 Host cell proteins interacting with the 3′ end of TGEV coronavirus genome influence virus replication
n 1073 Et les virus respiratoires !
n 1074 Selection of SARS-Coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice ☆
n 1075 Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin
n 1076 Complete Genome Sequence of a Severe Acute Respiratory Syndrome-Related Coronavirus from Kenyan Bats
n 1077 Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus
n 1078 Viral upper respiratory tract infections in young children with emphasis on acute otitis media
n 1079 Bird flu: lessons from SARS
n 1080 Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
n 1081 Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle
n 1082 Respiratory Viral Vaccines Chapter
n 1083 Polyprotein cleavage mechanism of SARS CoV M pro and chemical modification of the octapeptide
n 1084 Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion
n 1085 Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro
n 1086 Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients
n 1087 Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice
n 1088 SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
n 1089 Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods
n 1090 Construction and Genetic Analysis of Murine Hepatitis Virus Strain A59 Nsp16 Temperature Sensitive Mutant and the Revertant Virus *
n 1091 Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4 + and CD8 + T cells promote cellular immune responses
n 1092 Pathogenetic mechanisms of severe acute respiratory syndrome
n 1093 Diagnostic et traitement des viroses émergentes : com- ment aller de l'avant ? Diagnosis and treatment of emerging viral diseases : how can we do better ?
n 1094 A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
n 1095 The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models
n 1096 SARS-associated Coronavirus Transmitted from Human to Pig
n 1097 Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
n 1098 The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation
n 1099 Development of a Western Blot Assay for Detection of Antibodies against Coronavirus Causing Severe Acute Respiratory Syndrome
n 1100 Review Molecular Diagnosis of Severe Acute Respiratory Syndrome The State of the Art
n 1101 Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for Standardized Assays for Drug Discovery NIH Public Access
n 1102 A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2
n 1103 Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus
n 1104 Responding to the Severe Acute
n 1105 Immunogenic characterization and epitope mapping of transmissible gastroenteritis virus RNA dependent RNA polymerase
n 1106 SARS e My personal battle
n 1107 Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism
n 1108 Cardiovascular complications of severe acute respiratory syndrome
n 1109 pH-dependent Conformational Flexibility of the SARS-CoV Main Proteinase (M pro ) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses
n 1110 A universal microarray for detection of SARS coronavirus
n 1111 Clinical and Laboratory Features of Severe Acute Respiratory Syndrome Vis-À -Vis Onset of Fever*
n 1112 PCR-based diagnostics PCR-based diagnostics
n 1113 Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine
n 1114 siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
n 1115 The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors
n 1116 Neutralizing Antibody Response and SARS Severity Neutralizing Antibody Response and SARS Severity Neutralizing Antibody Response and SARS Severity
n 1117 Expression, purification and characterization of recombinant severe acute respiratory syndrome coronavirus non-structural protein 1 NIH Public Access SARS-CoV nsp1 Expression
n 1118 Reviews • DRUG DISCOVERY TODAY 345 www.drugdiscoverytoday.com From genome to antivirals: SARS as a test tube Metabolism-driven optimization of pharmacokinetics
n 1119 A new Sephadex TM -based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model
n 1120 Review SARS in Taiwan
n 1121 Rapid Identification of Emerging Pathogens: Coronavirus Rapid Identification of Emerging Pathogens
n 1122 Epidemiological study of influenza virus infections in young adult outpatients from Buenos Aires, Argentina
n 1123 Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors
n 1124 SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway
n 1125 A rapid point of care immunoswab assay for SARS-CoV detection
n 1126 Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
n 1127 Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice
n 1128 Identification of natural compounds with antiviral activities against SARS-associated coronavirus
n 1129 Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease
n 1130 Two novel bocaparvovirus species identified in wild Himalayan marmots
n 1131 Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine
n 1132 Concise Review for Clinicians SARS: Epidemiology, Clinical Presentation, Management, and Infection Control Measures
n 1133 Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome
n 1134 Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007
n 1135 Humoral and Cellular Immune Responses Induced by 3a DNA Vaccines against Severe Acute Respiratory Syndrome (SARS) or SARS-Like Coronavirus in Mice ᰔ
n 1136 Special Report Global outbreak of severe acute respiratory syndrome (SARS)
n 1137 Severe Acute Respiratory Syndrome: Temporal Stability and Geographic Variation in Case-Fatality Rates and Doubling Times
n 1138 Severe Acute Respiratory Syndrome in a Hemodialysis Patient
n 1139 Methods for Preparation of MS2 Phage-Like Particles and Their Utilization as Process Control Viruses in RT-PCR and qRT-PCR Detection of RNA Viruses From Food Matrices and Clinical Specimens
n 1140 Early diagnosis of SARS Coronavirus infection by real time RT-PCR
n 1141 A single amino acid mutation in the spike protein of coronavirus infectious bronchitis virus hampers its maturation and incorporation into virions at the nonpermissive temperature
n 1142 Ultrastructural Characterization of SARS Coronavirus EMERGENCE OF SARS
n 1143 Therapeutic Effect of Integrative Traditional Chinese and Western Medicine on 51 SARS Patients and Its Influence on Their T Lymphocyte Subsets*
n 1144 Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells
n 1145 Liver Disease Associated with Non-Hepatitis Viruses
n 1146 Index Patient and SARS Outbreak in Hong Kong DISPATCH CLINICAL STUDIES
n 1147 Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV
n 1148 Profile of Antibodies to the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Probable SARS Patients
n 1149 Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin NIH Public Access
n 1150 Establishment of a reference panel for the detection of anti-SARS-CoV antibodies *,**
n 1151 Commentary Middle East respiratory syndrome coronavirus infection control: The missing piece?
n 1152 Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates
n 1153 Le franchissement de la barrière inter-espèces : dernier obstacle avant la pandémie Cross-species transmission: Last obstacle before pandemic
n 1154 Survival of surrogate coronaviruses in water
n 1155 Coronavirus Pathogenesis
n 1156 Review Imaging in Severe Acute Respiratory Syndrome (SARS)
n 1157 Respiratory Viral Infections in Transplant and Oncology Patients
n 1158 VHL negatively regulates SARS coronavirus replication by modulating nsp16 ubiquitination and stability
n 1159 Coronavirus Infection and Hospitalizations for Acute Respiratory Illness in Young Children
n 1160 Topographic Changes in SARS Coronavirus-infected Cells during Late Stages of Infection
n 1161 Emerging Molecular Assays for Detection and Characterization of Respirator y Viruses
n 1162 Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion
n 1163 A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide
n 1164 Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
n 1165 Human monoclonal antibodies as candidate therapeutics against emerging viruses
n 1166 Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses
n 1167 Laboratory Diagnosis of SARS Laboratory Diagnosis of SARS Emerging Infectious Diseases • www
n 1168 In vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate
n 1169 Development and evaluation of an efficient 3 -noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections
n 1170 0 Real-time Fluorescent PCR Techniques to Study Microbial -Host Interactions
n 1171 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
n 1172 Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a
n 1173 Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry
n 1174 Virus discovery and recent insights into virus diversity in arthropods
n 1175 Les antirétroviraux ont-ils une place dans le traitement du syndrome respiratoire aigu sévère ?
n 1176 Risk Perceptions and Behaviour: Towards Pandemic Control of Emerging Infectious Diseases International Research on Risk Perception in the Control of Emerging Infectious Diseases
n 1177 Evaluation and Validation of an Enzyme-Linked Immunosorbent Assay and an Immunochromatographic Test for Serological Diagnosis of Severe Acute Respiratory Syndrome Downloaded from
n 1178 27Evolution of SARS Coronavirus and the Relevance of Modern Molecular Epidemiology
n 1179 Recombinant Protein-Based Enzyme-Linked Immunosorbent Assay and Immunochromatographic Tests for Detection of Immunoglobulin G Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus in SARS Patients
n 1180 Crystal Structures Reveal an Induced-fit Binding of a Substrate-like Aza-peptide Epoxide to SARS Coronavirus Main Peptidase
n 1181 Pneumonitis and Multi-Organ System Disease in Common Marmosets (Callithrix jacchus) Infected with the Severe Acute Respiratory Syndrome-Associated Coronavirus
n 1182 Severe acute respiratory syndrome and tuberculosis
n 1183 Development of Taqman RT-nested PCR system for clinical SARS-CoV detection
n 1184 REVIEW Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
n 1185 Biomedical Science Review SARS Virus: The Beginning of the Unraveling of a New Coronavirus
n 1186 Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein
n 1187 Virological surveillance of influenza-like illness in the community using PCR and serology
n 1188 SARS: future research and vaccine
n 1189 Narrative Review CKD of Unknown Origin in Central America: The Case for a Mesoamerican Nephropathy
n 1190 A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters
n 1191 Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: Comparison with results of other viral markers
n 1192 Cellular entry of the SARS coronavirus
n 1193 Human CD4 + memory T-lymphocyte responses to SARS coronavirus infection
n 1194 A S I P J o u r n a l C M E P r o g r a m Review Pathology and Pathogenesis of Severe Acute Respiratory Syndrome
n 1195 Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated
n 1196 Stability and inactivation of SARS coronavirus
n 1197 Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS
n 1198 Monitoring of viable airborne SARS virus in ambient air
n 1199 A molecular beacon, bead-based assay for the detection of nucleic acids by flow cytometry
n 1200 Characterization of viral proteins encoded by the SARS-coronavirus genome
n 1201 The Human Bocaviruses : A Review and Discussion of Their Role in Infection
n 1202 Characterization of a novel coronavirus responsible for severe acute respiratory syndrome
n 1203 The chronology of the 2002-2003 SARS mini pandemic
n 1204 Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Article Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
n 1205 Enzymatic activity of the SARS coronavirus main proteinase dimer
n 1206 Adenoviruses as Vaccine Vectors
n 1207 Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients
n 1208 Original Contributions COMPARATIVE STUDY OF PATIENTS WITH AND WITHOUT SARS WHO FULFILLED THE WHO SARS CASE DEFINITION
n 1209 Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59
n 1210 Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region
n 1211 Current concepts in SARS treatment
n 1212 Syndrome respiratoire aigu sévère : à propos d'un cas de transmission indirecte du Coronavirus Severe acute respiratory syndrome: one case of indirect transmission by Coronavirus
n 1213 Conséquences de l'épidémie de SRAS sur le système hospitalier de l'Ontario Consequences of the SARS outbreak on the Health Care System in Ontario
n 1214 Personal view SARS in Singapore Severe acute respiratory syndrome from the trenches, at a Singapore university hospital Paul A Tambyah
n 1215 Structural Basis of Severe Acute Respiratory Syndrome Coronavirus ADP-Ribose-1 00 -Phosphate Dephosphorylation by a Conserved Domain of nsP3
n 1216 Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses
n 1217 The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8 + T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848
n 1218 Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus
n 1219 Clathrin-independent entry of SARS-CoV 290 SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway
n 1220 The Pediatric Burden of Human Coronaviruses Evaluated For 20 Years NIH Public Access
n 1221 Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting
n 1222 Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus
n 1223 Detection of alpha and betacoronaviruses in multiple Iberian bat species
n 1224 Identification of a new region of SARS-CoV S protein critical for viral entry NIH Public Access Author Manuscript NIH-PA Author Manuscript
n 1225 Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells
n 1226 Actualités sur le syndrome respiratoire aigu sévère Severe acute respiratory syndrome: update
n 1227 Long-term SARS Coronavirus Excretion from Patient Cohort, China
n 1228 Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)
n 1229 Síndrome respiratorio agudo grave. Una nueva enfermedad infecciosa emergente
n 1230 Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells
n 1231 SARS Transmission and Commercial Aircraft
n 1232 Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus
n 1233 Differentiation between Human Coronaviruses NL63 and 229E Using a Novel Double-Antibody Sandwich Enzyme-Linked Immunosorbent Assay Based on Specific Monoclonal Antibodies ᰔ
n 1234 Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles
n 1235 How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past
n 1236 Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection ଝ
n 1237 Predicting linear B-cell epitopes using string kernels
n 1238 Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China
n 1239 Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets
n 1240 Peptide Mimicrying Between SARS Coronavirus Spike Protein and Human Proteins Reacts with SARS Patient Serum
n 1241 The Occupational and Psychosocial Impact of SARS on Academic Physicians in Three Affected Hospitals
n 1242 Coronavirus nucleocapsid protein is an RNA chaperone
n 1243 Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain
n 1244 A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
n 1245 Émergences et barrières d'espèces Emergence and species barriers
n 1246 SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
n 1247 THE 70TH ANNIVERSARY OF THE FOUNDING OF THE PEOPLE'S REPUBLIC OF CHINA: PREVENTION AND CONTROL OF MAJOR COMMUNICABLE DISEASES What we have learnt from the SARS epdemics in mainland China?
n 1248 Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
n 1249 SARS in Taiwan: an overview and lessons learned
n 1250 Use of Viral Lysate Antigen Combined with Recombinant Protein in Western Immunoblot Assay as Confirmatory Test for Serodiagnosis of Severe Acute Respiratory Syndrome
n 1251 Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol ® (Poly IC:LC), in a lethal SARS-CoV- infected BALB/c mouse model
n 1252 SARS among Critical Care Nurses, Toronto
n 1253 Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions
n 1254 Website 101 World Health Organization statistics. Future Virol
n 1255 HOSPITAL-ACQUIRED SARS IN TAIPEI, TAIWAN ORIGINAL ARTICLE
n 1256 Nosocomial Transmission of SARS
n 1257 Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure ☆
n 1258 Impact of a Viral Respiratory Epidemic on the Practice of Medicine and Rehabilitation: Severe Acute Respiratory Syndrome
n 1259 Detection of Four Human Coronaviruses in Respiratory Infections in Children: A One-Year Study in Colorado
n 1260 SARS CORONAVIRUS INFECTIONS OF THE LOWER RESPIRATORY TRACT AND THEIR PREVENTION
n 1261 SARS Molecular Detection External Quality Assurance
n 1262 The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
n 1263 Value of Initial Chest Radiographs for Predicting Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome
n 1264 Molecular methods for pathogen and microbial community detection and characterization: Current and potential application in diagnostic microbiology
n 1265 MOLECULAR BIOTECHNOLOGY De Novo Synthesis of PCR Template 107 RESEARCH 107 De Novo Synthesis of PCR Templates for the Development of SARS Diagnostic Assay
n 1266 Mouse models with human immunity and their application in biomedical research Molecular Cell Biology • Introduction • Recipient mouse selection for engrafting xenogeneic human haematopoietic and immune cells • Pre-conditioning regimens for establishing humanized mice -Depletion of innate immune cells in recipient mice -Implication of human growth factors -Making 'space' for donor cells by irradiation or chemical agents • Transplantation strategies to establish humanized mice -Humanized mice achieved by directly implanting mature human immune cells -Humanized mice established by engrafting human HSCs -Humanized mice achieved by engrafting human thymus and HSCs • A proposed ideal humanized mouse model • Applications of humanized mouse models in biomedical research -Ontogeny of human HSCs and immunocell lineages -Autoimmune diseases -Virus infections -Immune response or tolerance to allografts or xenografts -Anti-tumour immune response • Conclusions and perspectives
n 1267 Novel polymeric inhibitors of HCoV-NL63
n 1268 Longitudinal Surveillance of Betacoronaviruses in Fruit Bats in Yunnan
n 1269 EMERGENCE OF SARS EMERGENCE OF SARS
n 1270 A probable role for IFN-g in the development of a lung immunopathology in SARS
n 1271 Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
n 1272 A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
n 1273 Growth kinetics of SARS-coronavirus in Vero E6 cells
n 1274 Original Contributions VIRAL LOAD AND OUTCOME IN SARS INFECTION: THE ROLE OF PERSONAL PROTECTIVE EQUIPMENT IN THE EMERGENCY DEPARTMENT
n 1275 Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
n 1276 Infectious diseases
n 1277 Global threats from emerging viral diseases
n 1278 First external quality assurance of antibody diagnostic for SARS-new coronavirus
n 1279 ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes
n 1280 Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage
n 1281 Replicative Capacity of MERS Coronavirus in Livestock Cell Lines
n 1282 Guidelines for the management of adult lower respiratory tract infections -Full version
n 1283 Organic Carbamates in Drug Design and Medicinal Chemistry
n 1284 Update on bacterial pathogens: virulence and resistance Cercenado E et al. Update on bacterial pathogens: virulence and resistance Enferm Community-acquired methicillin-resistant Staphylococcus aureus
n 1285 The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated
n 1286 Coronavirus humains (HCoV) Human coronaviruses
n 1287 A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis
n 1288 Acute peristome edema disease in juvenile and adult sea cucumbers Apostichopus japonicus (Selenka) reared in North China
n 1289 Evaluation of a novel real-time RT-PCR using TOCE technology compared with culture and Seeplex RV15 for simultaneous detection of respiratory viruses
n 1290 Personal view Antiviral effects of chloroquine
n 1291 Animal Models of Human Viral Diseases
n 1292 Discovery, diversity and evolution of novel coronaviruses sampled from rodents in China
n 1293 Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus
n 1294 Efficacy of various disinfectants against SARS coronavirus
n 1295 Clinical Features and Outcomes of Severe Acute Respiratory Syndrome and Predictive Factors for Acute Respiratory Distress Syndrome
n 1296 Update on SARS research and other possibly zoonotic coronaviruses ଝ
n 1297 Recently Discovered Human Coronaviruses Coronaviruses Human coronavirus 229E Human coronavirus NL63 Human coronavirus OC43 Human coronavirus HKU1 Severe acute respiratory syndrome-associated coronavirus Recently Discovered Human Coronaviruses
n 1298 A SARS vaccine based on a live-attenuated vesicular stomatitis virus (VSV) recombinant expressing the SARS- CoV S protein provides long-term protection of immunized mice from SARS-CoV infection (
n 1299 BMC Infectious Diseases Date of origin of the SARS coronavirus strains
n 1300 Variable Oligomerization Modes in Coronavirus Non-structural Protein 9
n 1301 Severe acute respiratory syndrome coronavirus accessory proteins 6 and 9b interact in vivo
n 1302 Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential
n 1303 Chicken single-chain variable fragments against the SARS-CoV spike protein
n 1304 Tzong- Establishing a Clinical Decision Rule of Severe Acute Respiratory Syndrome at the Emergency Department J A N U A R Y 2 0 0 4 4 3 : 1 A N N A L S O F E M E R G E N C Y M E D I C I N E 1 7 J A N U A R Y 2 0 0 4 4 3 : 1 A N N A L S O F E M E R G E N C Y M E D I C I N E Address for reprints
n 1305 Inflammatory Lung Disease O.12.1 From SARS and avian flu to swine flu
n 1306 SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world ☆
n 1307 Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on SARS-CoV polymerase and other proteins
n 1308 A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)
n 1309 Domestic Poultry and SARS Coronavirus, Southern China
n 1310 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings
n 1311 Human memory T cell responses to SARS-CoV E protein
n 1312 In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
n 1313 VIROLOGICA SINICA, Expression of Prothrombinase/fibroleukin Gene fg12 in Lung Impairment in a Murine Severe Acute Respiratory Syndrome Model *
n 1314 Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
n 1315 COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives Trends in Molecular Medicine
n 1316 Human Coronavirus in Young Children Hospitalized for Acute Respiratory Illness and Asymptomatic Controls
n 1317 Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR
n 1318 Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections
n 1319 Are animals a bane for the spread of the deadly malady, the corona virus (MERS)? Asian Pacific Journal of Tropical Biomedicine journal homepage: www.apjtb.com
n 1320 Progress in Global Surveillance and Response Capacity 10 Years after Severe Acute Respiratory Syndrome
n 1321 Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies
n 1322 El síndrome respiratorio agudo grave: primera pandemia del siglo XXI
n 1323 The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1
n 1324 In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS
n 1325 Clinical, Laboratory, and Radiologic Manifestation of SARS
n 1326 SARS-CoV Attack (Severe Acute Respiratory Syndrome)
n 1327 CHAPTER17 Severe Acute Respiratory Syndrome: What Have We Learned A n outbreak of atypical pneumonia was noted in the Guangdong Severe Acute Respiratory Syndrome
n 1328 Molecular pathogenesis of severe acute respiratory syndrome
n 1329 Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
n 1330 Infection control for SARS in a tertiary neonatal centre
n 1331 Pathogenesis of SARS 1145
n 1332 Epidemiological and clinical features of human coronavirus infections among different subsets of patients
n 1333 Coronaviridae and SARS-associated Coronavirus Strain HSR1
n 1334 HexaPrime: A novel method for detection of coronaviruses
n 1335 Cell Type-Specific Cleavage of Nucleocapsid Protein by Effector Caspases during SARS Coronavirus Infection
n 1336 Immunization with SARS-CoV S DNA vaccine generates memory CD4 + and CD8 + T cell immune responses
n 1337 Serological Responses in Patients with Severe Acute Respiratory Syndrome Coronavirus Infection and Cross-Reactivity with Human Coronaviruses 229E, OC43, and NL63
n 1338 Syndrome respiratoire aigu sévère: une épidémie singulière de pneumonie virale Severe acute respiratory syndrome: a singular epidemic of viral pneumonia
n 1339 SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism
n 1340 The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned
n 1341 Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
n 1342 Avascular necrosis of bone in severe acute respiratory syndrome
n 1343 Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate q
n 1344 Reovirus, isolated from SARS patients
n 1345 Enteric Involvement of Severe Acute Respiratory Syndrome- Associated Coronavirus Infection
n 1346 The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis
n 1347 Sequential Symptomatic Analysis in Probable Severe Acute Respiratory Syndrome Cases J A N U A R Y 2 0 0 4 4 3 : 1 A N N A L S O F E M E R G E N C Y M E D I C I N E 2 7
n 1348 Special Article Severe Acute Respiratory Syndrome (SARS): A Review of the History, Epidemiology, Prevention, and Concerns for the Future
n 1349 Identification of two antigenic epitopes on SARS-CoV spike protein
n 1350 SARS-associated Coronavirus Replication in Cell Lines SARS-associated Coronavirus Replication in Cell Lines
n 1351 Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds
n 1352 Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
n 1353 Theoretically estimated risk of severe acute respiratory syndrome transmission through blood transfusion during an epidemic in Shenzhen, Guangdong, China in 2003
n 1354 The C-Terminal Portion of the Nucleocapsid Protein Demonstrates SARS-CoV Antigenicity
n 1355 One Health in China
n 1356 Vaccines for emerging pathogens: prospects for licensure
n 1357 Travel, migration and emerging infectious diseases
n 1358 Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)
n 1359 Animal viral diseases and global change: bluetongue and West Nile fever as paradigms
n 1360 New Respiratory Viruses and the Elderly
n 1361 Understanding Human Coronavirus HCoV-NL63
n 1362 Thirty Years into the Genomics Era: Tumor Viruses Led the Way
n 1363 Emerging Microbes and Infections (2012) 1, e13
n 1364 Advance Access Publication 29
n 1365 Inhibition of SARS-CoV 3CL protease by flavonoids
n 1366 A Correlation between the Severity of Lung Lesions on Radiographs and Clinical Findings in Patients with Severe Acute Respiratory Syndrome
n 1367 IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
n 1368 Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations
n 1369 Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence
n 1370 A novel coronavirus associated with severe acute respiratory syndrome
n 1371 Replication of SARS-CoV-2 in human respiratory Aleksandra Milewska a
n 1372 Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing
n 1373 Spreading predictability in complex networks
n 1374 Time Course and Cellular Localization of SARS-CoV Nucleoprotein and RNA in Lungs from Fatal Cases of SARS
n 1375 Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post- SARS syndrome; a case-controlled study
n 1376 Viral Discovery and Sequence Recovery Using DNA Microarrays
n 1377 Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections
n 1378 Characterization of the Viral Microbiome in Patients with Severe Lower Respiratory Tract Infections, Using Metagenomic Sequencing
n 1379 DV-Curve Representation of Protein Sequences and Its Application
n 1380 Open Access E-Predict: a computational strategy for species identification based on observed DNA microarray hybridization patterns
n 1381 Diagnostic value of respiratory virus detection in symptomatic children using real-time PCR
n 1382 Efficient oligonucleotide probe selection for pan-genomic tiling arrays
n 1383 Open Access Optimization and clinical validation of a pathogen detection microarray
n 1384 Open Access R440 Pneumothorax and mortality in the mechanically ventilated SARS patients: a prospective clinical study
n 1385 Simultaneous Detection and Differentiation of Human Papillomavirus Genotypes 6, 11, 16 and 18 by AllGlo Quadruplex Quantitative PCR
n 1386 MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells
n 1387 MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
n 1388 Information theory-based algorithm for in silico prediction of PCR products with whole genomic sequences as templates
n 1389 Seroepidemiologic Survey of Potential Pathogens in Obligate and Facultative Scavenging Avian Species in California
n 1390 Novel canine circovirus strains from Thailand: Evidence for genetic recombination
n 1391 Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults
n 1392 Feline bocavirus-1 associated with outbreaks of hemorrhagic enteritis in household cats: potential first evidence of a pathological role, viral tropism and natural genetic recombination
n 1393 HCoV interactions with renin-angiotensin proteases Renin-angiotensin system in human coronavirus pathogenesis
n 1394 Household transmission of respiratory viruses -assessment of viral, individual and household characteristics in a population study of healthy Australian adults
n 1395 BMC Public Health Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003
n 1396 Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway
n 1397 Virology Journal The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization
n 1398 Co-circulation of Four Human Coronaviruses (HCoVs) in Queensland Children with Acute Respiratory Tract Illnesses in 2004
n 1399 Double-Stranded RNA Attenuates the Barrier Function of Human Pulmonary Artery Endothelial Cells
n 1400 Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats
n 1401 ZCURVE_V: a new self-training system for recognizing protein-coding genes in viral and phage genomes
n 1402 Severe varicella-zoster virus pneumonia: a multicenter cohort study
n 1403 Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses?
n 1404 A framework for the study of zoonotic disease emergence and its drivers: spillover of bat pathogens as a case study
n 1405 Use of functional gene arrays for elucidating in situ biodegradation
n 1406 Proteomics of Bronchoalveolar Lavage Fluid Reveals a Lung Oxidative Stress Response in Murine Herpesvirus-68 Infection
n 1407 Depletion of Alveolar Macrophages Ameliorates Virus- Induced Disease following a Pulmonary Coronavirus Infection
n 1408 Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong
n 1409 Laboratory Diagnosis of Respiratory Tract Infections in Children -the State of the Art
n 1410 High diversity of picornaviruses in rats from different continents revealed by deep sequencing
n 1411 The Emerging Roles of Viroporins in ER Stress Response and Autophagy Induction during Virus Infection
n 1412 BMC Genomics Sequence space coverage, entropy of genomes and the potential to detect non-human DNA in human samples
n 1413 Emergence of infectious malignant thrombocytopenia in Japanese macaques (Macaca fuscata) by SRV-4 after transmission to a novel host
n 1414 Individual sequences in large sets of gene sequences may be distinguished efficiently by combinations of shared sub-sequences
n 1415 SARS Coronavirus nsp1 Protein Induces Template- Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage
n 1416 The interface of animal and human vaccines Editorial overview
n 1417 EDITORIAL COMMENT
n 1418 Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS Coronavirus Downloaded from
n 1419 Contamination of healthcare workers' mobile phones by epidemic viruses
n 1420 Lack of SARS Transmission among Public Hospital Workers, Vietnam
n 1421 Management of inpatients exposed to an outbreak of severe acute respiratory syndrome (SARS)
n 1422 Down-regulation of granulocyte-macrophage colony-stimulating factor by 3C-like proteinase in transfected A549 human lung carcinoma cells
n 1423 Production of an Anti-Severe Acute Respiratory Syndrome (SARS) Coronavirus Human Monoclonal Antibody Fab Fragment by Using a Combinatorial Immunoglobulin Gene Library Derived from Patients Who Recovered from SARS
n 1424 SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
n 1425 Applications of Molecular Tools to Infectious Disease Epidemiology
n 1426 • Bacterial Infections 64 • Fungal Infections 67 • Protozoal Infections 68 • Emerging Infectious Diseases 69 • Pathologists, Immunohistochemistry, and Bioterrorism 70 • Beyond Immunohistology: Molecular Diagnostic Applications 72 3 Immunohistology of Infectious Diseases
n 1427 -Year Pulmonary Function and Health Status in Survivors of Severe Acute Respiratory Syndrome*
n 1428 International Journal of Antimicrobial Agents
n 1429 WSE, a new sequence distance measure based on word frequencies
n 1430 Traditional and syndromic surveillance of infectious diseases and pathogens
n 1431 Materno-fetal transmission of human coronaviruses: a prospective pilot study
n 1432 Antigenic and cellular localisation analysis of the severe acute respiratory syndrome coronavirus nucleocapsid protein using monoclonal antibodies
n 1433 Viral Chip Technology in Genomic Medicine
n 1434 Clinical Communications SARS AND ITS IMPACT ON CURRENT AND FUTURE EMERGENCY DEPARTMENT OPERATIONS
n 1435 Group-specific structural features of the 5′-proximal sequences of coronavirus genomic RNAs
n 1436 SARS-coronavirus replication in human peripheral monocytes/macrophages
n 1437 Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction
n 1438 The SARS-CoV ferret model in an infection-challenge study
n 1439 New Academic Partnerships in Global Health: Innovations at Mount Sinai School of Medicine NIH Public Access Author Manuscript
n 1440 Structural insights of a self-assembling 9-residue peptide from the C- terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study
n 1441 Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS)
n 1442 Enteric Coronavirus in Ferrets, the Netherlands
n 1443 Human airway epithelial cell culture to identify new respiratory viruses: Coronavirus NL63 as a model
n 1444 Genomic Analysis Reveals Age-Dependent Innate Immune Responses to Severe Acute Respiratory Syndrome Coronavirus ᰔ †
n 1445 Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome
n 1446 Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein
n 1447 Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein
n 1448 Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: A deadly viral epidemic begins
n 1449 Additional file 2 -Estimation of divergence time
n 1450 An atypical RNA pseudoknot stimulator and an upstream attenuation signal for À1 ribosomal frameshifting of SARS coronavirus
n 1451 Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells
n 1452 0Infectious Disease Genomics
n 1453 A high-flow portable biological aerosol trap (HighBioTrap) for rapid microbial detection
n 1454 Animal models for SARS and MERS coronaviruses
n 1455 Reducing the Impact of Viral Respiratory Infections in Children
n 1456 Co-stimulation: novel methods for preventing viral-induced lung inflammation
n 1457 Monoclonal Antibody-Based Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Sensitivity of the Nucleocapsid Protein in Acute-Phase Sera of Severe Acute Respiratory Syndrome Patients
n 1458 Protease inhibitors and their peptidomimetic derivatives as potential drugs
n 1459 Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice
n 1460 Epidemiology of severe acute respiratory syndrome (SARS): adults and children
n 1461 Immunohistology of Infectious Diseases
n 1462 NOTES Retrospective Serological Investigation of Severe Acute Respiratory Syndrome Coronavirus Antibodies in Recruits from Mainland China Downloaded from
n 1463 Identification of the relative timing of infectiousness and symptom onset for outbreak control
n 1464 THE MOLECULAR BIOLOGY OF CORONAVIRUSES
n 1465 Le bocavirus humain (HBoV) Human bocavirus (HBoV)
n 1466 TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
n 1467 Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E ଝ
n 1468 Clinical Presentation and Outcome of Severe Acute Respiratory Syndrome in Dialysis Patients
n 1469 Receptor recognition and cross-species infections of SARS coronavirus
n 1470 Structure, Evolutionary Conservation, and Functions of Angiotensin-and Endothelin-Converting Enzymes
n 1471 Lung infections and aging
n 1472 Role of Electron Microscopy in Modern Diagnostic Surgical Pathology THE TRANSMISSION ELECTRON MICROSCOPE PROCEDURE FOR EVALUATING DIAGNOSTIC PROBLEMS NON-NEOPLASTIC DISEASES Glomerulopathies Microbial Diseases Cilia Abnormalities Microvillous Inclusion Disease Lysosomal Storage Diseases Bullous Skin Disorders CADASIL Peripheral Neuropathies Striated Muscle Diseases NEOPLASTIC DISEASES Mesothelioma or Adenocarcinoma Soft Tissue Tumors Gastrointestinal Stromal Tumors Clear Cell Ependymoma Dendritic Reticulum Cell Sarcoma True Oncocytomas and "Granular" Renal Epithelial Tumors The Unknown Primary
n 1473 Transmission of Severe Acute Respiratory Syndrome in an Emergency Department
n 1474 The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation
n 1475 Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
n 1476 Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats
n 1477 Severe Childhood Respiratory Viral Infections
n 1478 Assembly of human severe acute respiratory syndrome coronavirus-like particles
n 1479 Short Term Outcome and Risk Factors for Mortality in Adults with Criti- cal Severe Acute Respiratory Syndrome (SARS)
n 1480 Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein
n 1481 The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein
n 1482 Emerging and Reemerging Virus Diseases of Vertebrates ☆
n 1483 REVIEW A Systematic Approach to Novel Virus Discovery in Emerging Infectious Disease Outbreaks
n 1484 Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection
n 1485 Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus
n 1486 TEACHERS' TOPICS A Learner-led, Discussion-based Elective on Emerging Infectious Disease
n 1487 Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo
n 1488 Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53
n 1489 Morphology and Morphogenesis of Severe Acute Respiratory Syndrome (SARS)-associated Virus
n 1490 Expression and puriWcation of SARS coronavirus proteins using SUMO-fusions
n 1491 Development of Recombinant Nucleoprotein-Based Diagnostic Systems for Lassa Fever ᰔ
n 1492 ORF8a of SARS-CoV forms an ion channel: Experiments and molecular dynamics simulations
n 1493 Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms
n 1494 The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function
n 1495 Cell Culture and Electron Microscopy for Identifying Viruses in Diseases of Unknown Cause
n 1496 Thin-section CT assessment of spontaneous pneumomediastinum in interstitial lung disease: Correlation with serial changes in lung parenchymal abnormalities $
n 1497 Comparison of Immunoglobulin G Responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS ᰔ
n 1498 Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
n 1499 Keeping Track of Viruses
n 1500 Treatment of respiratory virus infections
n 1501 THE JOURNAL O F Allergy AND Clinical Immunology Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
n 1502 SECTION VII INFECTIOUS DISEASES 28 Nonbacterial Pneumonia VIRAL PNEUMONIA
n 1503 Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
n 1504 KEYWORDS Pneumonia Virus Influenza Epidemic
n 1505 SARS Clinical Features, United States, 2003 for the CDC SARS Clinical Investigation Team 3
n 1506 Recombinant Truncated Nucleocapsid Protein as Antigen in a Novel Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus Infection ᰔ
n 1507 Lack of SARS Transmission among Healthcare Workers, United States EMERGENCE OF SARS EMERGENCE OF SARS Search past issues of EID at www.cdc.gov/eid
n 1508 Interferon alfacon 1 inhibits SARS-CoV infection In human bronchial epithelial Calu-3 cells
n 1509 Pneumopathie à métapneumovirus humain chez un adulte suspect de syndrome respiratoire aigu sévère (Sras) Cas clinique Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respira- tory syndrome (SARS)
n 1510 Identification of an epitope of SARS-coronavirus nucleocapsid pro- tein
n 1511 Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial
n 1512 Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43
n 1513 Epidemiology and etiology of community-acquired pneumonia
n 1514 Human coronavirus NL63 infections in infants hospitalised with acute respiratory tract infections in South Africa
n 1515 Application of transmission electron microscopy to the clinical study of viral and bacterial infections: Present and future
n 1516 The Crystal Structure of ORF-9b, a Lipid Binding Protein from the SARS Coronavirus
n 1517 NOTES Use of the COOH Portion of the Nucleocapsid Protein in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay for Specific and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus Downloaded from
n 1518 Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain
n 1519 A novel application of small-angle scattering techniques: Quality assurance testing of virus quantification technology
n 1520 Virus-mediated modulation of the host endocrine signaling systems: clinical implications
n 1521 ScienceDirect Quelle place et quel avenir pour l'anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ? What place and what future for the pathology of infectious and tropical diseases in France?
n 1522 Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets
n 1523 Other Viral, Bacterial, Parasitic and Prion-Based Infectious Complications III 652
n 1524 Search past issues of EID at www.cdc.gov/eid
n 1525 Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
n 1526 Detection and Prevalence Patterns of Group I Coronaviruses in Bats, Northern Germany
n 1527 Mycobacterium tuberculosis Antigen 85A Induces Th-1 Immune Responses in Systemic Sarcoidosis
n 1528 Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus
n 1529 Coronavirus Antibodies in Bat Biologists
n 1530 Coronavirus Antibodies in African Bat Species
n 1531 Review of Bats and SARS
n 1532 Infection control practices for SARS in Lao People's Democratic Republic, Taiwan, and Thailand: Experience from mobile SARS containment teams, 2003
n 1533 Gene Expression Profiling: From Microarrays to Medicine
n 1534 Moderate mutation rate in the SARS coronavirus genome and its implications
n 1535 Activation of human monocytes after infection by human coronavirus 229E
n 1536 IV Infections of the Respiratory Tract 22 Diagnosis of Viral Respiratory Illness: Practical Applications DIAGNOSIS OF VIRAL RESPIRATORY ILLNESS: PRACTICAL APPLICATIONS
n 1537 Category C Potential Bioterrorism Agents and Emerging Pathogens
n 1538 Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein
n 1539 Mechanical Ventilation in an Airborne Epidemic
n 1540 Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients
n 1541 Chapter 16 Carbohydrate Microarrays as Essential Tools of Postgenomic Medicine
n 1542 Viral and bacterial aetiology of community-acquired pneumonia in adults
n 1543 4 What is a medical theory?
n 1544 Contribution of the porcine aminopeptidase N (CD13) receptor density to porcine epidemic diarrhea virus infection
n 1545 Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus
n 1546 Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV
n 1547 Functional genomics as a tool in virus research
n 1548 Kinetics of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibodies in 271 Laboratory-Confirmed Cases of SARS
n 1549 Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines
n 1550 Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong
n 1551 Genomic and proteomic approaches for studying human cancer: Prospects for true patient-tailored therapy
n 1552 DIFFERENTIATED CULTURES OF PRIMARY HAMSTER TRACHEAL AIRWAY EPITHELIAL CELLS
n 1553 Original Articles Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates
n 1554 Expression, puriWcation and characterization of recombinant severe acute respiratory syndrome coronavirus non-structural protein 1
n 1555 Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan
n 1556 Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain
n 1557 Pathological Changes in Masked Palm Civets Experimentally Infected by Severe Acute Respiratory Syndrome (SARS) Coronavirus
n 1558 Emerging and Reemerging Virus Diseases of Vertebrates
n 1559 Biochemical Terrorism: The Medical Threat in the Twenty-First Century
n 1560 Estimation of the impact of providing outpatients with information about SARS infection control on their intention of outpatient visit
n 1561 Asymptomatic SARS Coronavirus Infection among Healthcare Workers, Singapore
n 1562 The expression of SARS-CoV M gene in P. Pastoris and the diagnostic utility of the expression product
n 1563 Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
n 1564 SARS Coronavirus Detection Methods
n 1565 ScienceDirect Interactions micro-organismes et voies aériennes distales : spécificités pédiatriques The interactions between microorganisms and the small airways. A paediatric focus
n 1566 Journal of Infection The Clinical Characteristics of Myocardial injury 1 in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease
n 1567 Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice ᰔ
n 1568 SARS-CoV Replication and Pathogenesis in an In Vitro Model of the Human Conducting Airway Epithelium NIH Public Access
n 1569 Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
n 1570 Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions
n 1571 Approach to Common Bacterial Infections: Community-Acquired Pneumonia
n 1572 Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya
n 1573 Transmission maternofoetale des coronavirus humains. Étude prospective pilote Vertical transmission of human coronavirus. Prospective pilot study
n 1574 Molecular Diagnostics and Comparative Genomics in Clinical Microbiology Chapter 30
n 1575 Molecular analysis of Idiopathic Subglottic Stenosis for Mycobacterium species: A North American Airway Collaborative (NoAAC) TS-04 study HHS Public Access
n 1576 Design and validation of consensus-degenerate hybrid oligonucleotide primers for broad and sensitive detection of corona-and toroviruses
n 1577 Individual and common inhibitors of coronavirus and picornavirus main proteases
n 1578 Sero-prevalence, cross-species infection and serological determinants of prevalence of Bovine Coronavirus in Cattle, Sheep and Goats in Ghana
n 1579 The etiologic role of infectious antigens in sarcoidosis pathogenesis
n 1580 Mapping a Neutralizing Epitope on the SARS Coronavirus Spike Protein: Computational Prediction Based on Affinity-selected Peptides
n 1581 Autochthonous dengue infections were last reported in Hawaii
n 1582 Quantitative Proteomics Analysis Reveals BAG3 as a Potential Target To Suppress Severe Acute Respiratory Syndrome Coronavirus Replication ᰔ
n 1583 A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage
n 1584 Geographical structure of bat SARS-related coronaviruses
n 1585 Factors influencing the wearing of facemasks to prevent the severe acute respiratory syndrome among adult Chinese in Hong Kong
n 1586 Inhibition of SARS-CoV replication by siRNA
n 1587 Structural Lability in Stem-Loop 1 Drives a 5′ UTR-3′ UTR Interaction in Coronavirus Replication
n 1588 Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference
n 1589 T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
n 1590 Communicable Respiratory Threats in the ED: Tuberculosis, Influenza, SARS, and Other Aerosolized Infections
n 1591 A Poisson model of sequence comparison and its application to coronavirus phylogeny
n 1592 Secondary Household Transmission of SARS, Singapore EMERGENCE OF SARS
n 1593 Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
n 1594 Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models
n 1595 Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells
n 1596 Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents
n 1597 Send Orders of Reprints at bspsaif@emirates.net.ae The Open Virology Journal
n 1598 Evolution and Variation of the SARS-CoV Genome
n 1599 The Epitope Study on the SARS-CoV Nucleocapsid Protein
n 1600 Emerging Microbes and Infections (2012) 1, e23
n 1601 Origin, Evolution, and Genotyping of Emergent Porcine Epidemic Diarrhea Virus Strains in the United States
n 1602 Microarrays for Pathogen Detection and Analysis
n 1603 Perspectives of public health laboratories in emerging infectious diseases
n 1604 Therapeutics and Clinical Risk Management Dovepress a 12-year follow-up study of combined treatment of post-severe acute respiratory syndrome patients with femoral head necrosis
n 1605 The Utility of Preliminary Patient Evaluation in a Febrile Respiratory Infectious Disease Unit outside the Emergency Department
n 1606 Identification of a Severe Acute Respiratory Syndrome Coronavirus- Like Virus in a Leaf-Nosed Bat in Nigeria
n 1607 A Strategy for Searching Antigenic Regions in the SARS-CoV Spike Protein
n 1608 The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung
n 1609 Coronavirus as a possible cause of severe acute respiratory syndrome
n 1610 More than efficacy revealed by single-cell analysis of antiviral therapeutics
n 1611 Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis
n 1612 Detection of human bocavirus from children and adults with acute respiratory tract illness in Guangzhou, southern China
n 1613 Clinical Study Epidemiology of Human Respiratory Viruses in Children with Acute Respiratory Tract Infections in Jinan, China
n 1614 Virology Journal Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers
n 1615 Is It Just a Marker for Increased Care?
n 1616 Identification of Novel Rosavirus Species That Infects Diverse Rodent Species and Causes Multisystemic Dissemination in Mouse Model Identification of Novel Rosavirus Species That Infects Diverse Rodent Species and Causes Multisystemic Dissemination in Mouse Model
n 1617 ): e1002369. Minister of Health of China
n 1618 Coronavirus Spike Protein Inhibits Host Cell Translation by Interaction with eIF3f
n 1619 Identification of Hepatotropic Viruses from Plasma Using Deep Sequencing: A Next Generation Diagnostic Tool
n 1620 Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response
n 1621 BMC Immunology Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells
n 1622 SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target
n 1623 The Search for a Practical Approach to Emerging Diseases: The Case of Severe Acute Respiratory Syndrome (SARS)
n 1624 Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China
n 1625 Coronavirus and paramyxovirus in bats from Northwest Italy
n 1626 Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice
n 1627 Open Access RESEARCH Interactions of SARS Coronavirus Nucleocapsid Protein with the host cell proteasome subunit p42
n 1628 Clinical characteristics and viral etiologies of outpatients with acute respiratory infections in Huzhou of China: a retrospective study
n 1629 Opinion Pathogen Discovery
n 1630 Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses
n 1631 Novel Bat Alphacoronaviruses in Southern China Support Chinese Horseshoe Bats as an Important Reservoir for Potential Novel Coronaviruses
n 1632 Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication
n 1633 Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019- nCoV) outbreak
n 1634 The S2 Subunit of QX-type Infectious Bronchitis Coronavirus Spike Protein Is an Essential Determinant of Neurotropism
n 1635 Crystal Structure of the C-Terminal Cytoplasmic Domain of Non-Structural Protein 4 from Mouse Hepatitis Virus A59
n 1636 Human rhinovirus C: a newly discovered human rhinovirus species
n 1637 Virus Pathogen Database and Analysis Resource (ViPR): A Comprehensive Bioinformatics Database and Analysis Resource for the Coronavirus Research Community
n 1638 SCIENCE CHINA Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China
n 1639 Feline and Canine Coronaviruses: Common Genetic and Pathobiological Features
n 1640 SCIENCE CHINA Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis
n 1641 A Rapid and Specific Assay for the Detection of MERS-CoV
n 1642 Identification of a Novel Bat Papillomavirus by Metagenomics
n 1643 Print) 2225-2002 Clinical Care in Africa
n 1644 Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
n 1645 Revue générale Infections à Bocavirus humain Human Bocavirus Infections
n 1646 Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus
n 1647 BMC Microbiology Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy
n 1648 United Christian Hospital
n 1649 Development of attenuated vaccines from Taiwanese infectious bronchitis virus strains
n 1650 High incidence of human bocavirus infection in children in Spain
n 1651 Identification and complete genome analysis of three novel paramyxoviruses, Tuhoko virus 1, 2 and 3, in fruit bats from China
n 1652 Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity
n 1653 Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells NIH Public Access Author Manuscript
n 1654 Avian influenza H5N1 in viverrids: implications for wildlife health and conservation
n 1655 A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
n 1656 The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases
n 1657 Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity NIH Public Access Author Manuscript Materials and methods Inhibition assay of live SARS-CoV infection
n 1658 SARS-CoV Infection in a Restaurant from Palm Civet SARS-CoV Infection in a Restaurant from Palm Civet Emerging Infectious Diseases • www Past Issues on SARS
n 1659 Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
n 1660 Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection
n 1661 Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates
n 1662 Asymptomatic Severe Acute Respiratory Syndrome-associ- ated Coronavirus Infection
n 1663 Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
n 1664 Human Bocavirus in Hospitalized Children, South Africa
n 1665 The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study
n 1666 Naturally Occurring Anti-Escherichia coli Protein Antibodies in the Sera of Healthy Humans Cause Analytical Interference in a Recombinant Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Severe Acute Respiratory Syndrome ᰔ
n 1667 Short Communication Experimental Human Metapneumovirus Infection of Cynomolgus Macaques (Macaca fascicularis) Results in Virus Replication in Ciliated Epithelial Cells and Pneumocytes with Associated Lesions throughout the Respiratory Tract
n 1668 Specific Immunoglobulin G Antibody Detected in Umbilical Blood and Amniotic Fluid from a Pregnant Woman Infected by the Coronavirus Associated with Severe Acute Respiratory Syndrome
n 1669 Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus
n 1670 The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
n 1671 From the University of Virginia Health System
n 1672 Network theory and SARS: predicting outbreak diversity
n 1673 Clinical management and infection control of SARS: Lessons learned
n 1674 Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells
n 1675 Severe Acute Respiratory Syndrome (SARS) in Hong Kong: Patients' Experiences
n 1676 Genetic diversity of coronaviruses in bats in Lao PDR and Cambodia
n 1677 The performance of RT-PCR compared with a rapid serological assay for acute dengue fever in a diagnostic laboratory
n 1678 Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
n 1679 SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
n 1680 siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA
n 1681 Molecular epidemiology, evolution and phylogeny of SARS coronavirus
n 1682 Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management
n 1683 Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice
n 1684 Psychiatric-Medical Comorbidity Long-term psychiatric morbidities among SARS survivors
n 1685 The diversity of human RNA viruses Europe PMC Funders Group
n 1686 Medical treatment of viral pneumonia including SARS in immunocompetent adult
n 1687 Serum neopterin for early assessment of severity of severe acute respiratory syndrome
n 1688 SARS-CoV nucleocapsid protein interacts with cellular pyruvate kinase protein and inhibits its activity
n 1689 Journal Pre-proof Evolutionary genetics of canine respiratory coronavirus and recent introduction into Swedish dogs
n 1690 MERS coronavirus outbreak: Implications for emerging viral infections
n 1691 Viral etiology of influenza-like illnesses in Huizhou, China, from 2011 to 2013
n 1692 Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis
n 1693 Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus
n 1694 Syndrome respiratoire aigu sévère Severe acute respiratory syndrome
n 1695 Detection of human rhinovirus C in fecal samples of children with gastroenteritis
n 1696 Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection HHS Public Access
n 1697 Late Recognition of SARS in Nosocomial Outbreak, Toronto
n 1698 Antigenic characterization of severe acute respiratory syndrome-coronavirus nucleocapsid protein expressed in insect cells: The effect of phosphorylation on immunoreactivity and specificity
n 1699 Respiratory virus infections
n 1700 Prokaryotic expression, refolding, and puriWcation of fragment 450-650 of the spike protein of SARS-coronavirus
n 1701 Innate Immunity Porcine Reproductive and Respiratory Syndrome Virus-Induced Immunosuppression Exacerbates the Inflammatory Response to Porcine Respiratory Coronavirus in Pigs
n 1702 A N N A L S O F E M E R G E N C Y M E D I C I N E 4 3 : 1 J A N U A R Y 2 0 0 4 I N F E C T I O U S D I S E A S E / O R I G I N A L R E S E A R C H Validation of a Novel Severe Acute Respiratory Syndrome Scoring System
n 1703 Interferon-β β 1a and SARS Coronavirus Replication
n 1704 Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome
n 1705 Respiratory viral diseases: access to RNA interference therapy
n 1706 Negatively charged residues in the endodomain are critical for specific assembly of spike protein into murine coronavirus
n 1707 KEYWORDS SARS Clinical features Pathogenesis Treatment Outcome
n 1708 Development of Animal Models Against Emerging Coronaviruses: From SARS to MERS coronavirus
n 1709 Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model
n 1710 Interactions between M protein and other structural proteins of severe, acute respiratory syndrome-associated coronavirus
n 1711 Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL pro †
n 1712 Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells
n 1713 Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
n 1714 SARS and Common Viral Infections
n 1715 A six-year descriptive epidemiological study of human coronavirus infections in hospitalized patients in Hong Kong
n 1716 International research networks in viral structural proteomics: Again, lessons from SARS
n 1717 Canine Respiratory Coronavirus: An Emerging Pathogen in the Canine Infectious Respiratory Disease Complex
n 1718 Up-regulation of IL-6 and TNF-␣ induced by SARS-coronavirus spike protein in murine macrophages via NF-B pathway
n 1719 Non-viral siRNA delivery to the lung ☆
n 1720 Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population ᰔ
n 1721 Invertebrate RNA virus diversity from a taxonomic point of view
n 1722 Infection control for SARS in a tertiary paediatric centre in Hong Kong
n 1723 Long Range Cooperative Interactions Modulate Dimerization in SARS 3CL pro NIH Public Access Author Manuscript
n 1724 23 Response to SARS as a prototype for bioterrorism: Lessons in a Regional Hospital in Hong Kong
n 1725 Infections virales émergentes
n 1726 RNA interference and antiviral therapy
n 1727 Pathologie infectieuse Virus émergents ou menaces à répétition
n 1728 ScienceDirect Article original Agents infectieux émergents Emerging infectious agents
n 1729 Robots, pipelines, polyproteins: Enabling multiprotein expression in prokaryotic and eukaryotic cells
n 1730 LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
n 1731 The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis $
n 1732 Acute Febrile Respiratory Illness in the ICU* Reducing Disease Transmission CHEST Recent Advances in Chest Medicine Recent Advances in Chest Medicine
n 1733 The Board of Management and Trustees of the
n 1734 Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses
n 1735 Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patients
n 1736 Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak
n 1737 Pneumonie virale sévère de l'immunocompétent Viral pneumonia in immunocompetent patients
n 1738 Benzotriazole: An overview on its versatile biological behavior
n 1739 Phylogenetic analysis of human coronavirus NL63 circulating in Italy
n 1740 EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF HEART TRANSPLANT RECIPIENTS DURING THE 2019 CORONAVIRUS OUTBREAK IN WUHAN, CHINA: A DESCRIPTIVE SURVEY REPORT
n 1741 SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway
n 1742 A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus
n 1743 International Research Networks in Viral Structural Proteomics: again, lessons from SARS
n 1744 The spike protein of SARS-CoV -a target for vaccine and therapeutic development
n 1745 The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein and induces the activation of ATF6
n 1746 Pulmonary DNA vaccination: Concepts, possibilities and perspectives
n 1747 Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: Implications for the functional roles of S2 subunit q
n 1748 Near-infrared spectroscopy: Promising diagnostic tool for viral infections
n 1749 Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein
n 1750 NMR assignment of the domain 513-651 from the SARS-CoV nonstructural protein nsp3
n 1751 Diagnostics and Discovery in Viral Hemorrhagic Fevers
n 1752 A review of vaccine research and development: Human acute respiratory infections ଝ
n 1753 Microwave-assisted tissue processing for same-day EM-diagnosis of potential bioterrorism and clinical samples
n 1754 Molecular diversity of coronaviruses in bats
n 1755 Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
n 1756 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
n 1757 ARTICLE 415 Multiple organ infection and the pathogenesis of SARS
n 1758 Emerging Microbes and Infections (2012) 1, e31
n 1759 CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes
e 0 1
e 2 1
e 3 1
e 4 1
e 5 1
e 5 748
e 6 1
e 7 1
e 7 1609
e 8 1
e 9 1
e 9 748
e 10 1
e 11 1
e 12 1
e 12 748
e 13 1
e 14 1
e 14 748
e 15 1
e 15 1370
e 16 1
e 16 1609
e 17 1
e 18 1
e 19 1
e 20 1
e 21 1
e 22 1
e 23 1
e 24 1
e 25 1
e 26 1
e 27 1
e 28 1
e 29 1
e 30 1
e 30 748
e 30 1370
e 30 1609
e 31 1
e 32 1
e 33 1
e 34 1
e 35 1
e 36 1
e 37 1
e 37 748
e 37 1370
e 37 1609
e 38 1
e 38 748
e 38 1370
e 39 1
e 39 748
e 39 1370
e 39 1609
e 40 1
e 41 1
e 42 1
e 43 1
e 44 1
e 45 1
e 46 1
e 47 1
e 47 1370
e 48 1
e 49 1
e 50 1
e 51 1
e 51 748
e 52 1
e 53 1
e 54 1
e 54 748
e 55 1
e 56 1
e 57 1
e 57 1609
e 58 1
e 59 1
e 60 1
e 61 1
e 61 748
e 61 1370
e 62 1
e 63 1
e 64 1
e 64 1370
e 64 1609
e 65 1
e 66 1
e 67 1
e 68 1
e 68 1609
e 69 1
e 70 1
e 71 1
e 72 1
e 73 1
e 74 1
e 75 1
e 75 1370
e 75 1609
e 76 1
e 76 748
e 76 1370
e 77 1
e 78 1
e 79 1
e 79 748
e 79 1370
e 80 1
e 80 1609
e 81 1
e 82 1
e 83 1
e 84 1
e 85 1
e 86 1
e 86 1609
e 87 1
e 88 1
e 89 1
e 90 1
e 91 1
e 92 1
e 93 1
e 94 1
e 95 1
e 96 1
e 97 1
e 98 1
e 99 1
e 99 748
e 100 1
e 101 1
e 102 1
e 103 1
e 104 1
e 105 1
e 106 1
e 107 1
e 108 1
e 109 1
e 110 1
e 111 1
e 111 748
e 111 1370
e 111 1609
e 112 1
e 113 1
e 114 1
e 115 1
e 116 1
e 116 748
e 117 1
e 118 1
e 119 1
e 120 1
e 121 1
e 122 1
e 123 1
e 124 1
e 124 1609
e 125 1
e 126 1
e 127 1
e 128 1
e 129 1
e 130 1
e 131 1
e 131 1609
e 132 1
e 133 1
e 134 1
e 135 1
e 136 1
e 136 748
e 136 1370
e 137 1
e 138 1
e 139 1
e 140 1
e 141 1
e 142 1
e 143 1
e 144 1
e 144 748
e 145 1
e 145 748
e 145 1370
e 146 1
e 147 1
e 148 1
e 149 1
e 149 748
e 149 1370
e 149 1609
e 150 1
e 151 1
e 151 748
e 151 1370
e 152 1
e 153 1
e 154 1
e 155 1
e 155 1370
e 156 1
e 157 1
e 158 1
e 159 1
e 160 1
e 161 1
e 161 748
e 161 1609
e 162 1
e 162 748
e 163 1
e 163 1609
e 164 1
e 164 748
e 165 1
e 166 1
e 167 1
e 168 1
e 169 1
e 170 1
e 171 1
e 172 1
e 173 1
e 174 1
e 175 1
e 175 748
e 175 1370
e 175 1609
e 176 1
e 177 1
e 178 1
e 179 1
e 180 1
e 181 1
e 181 748
e 181 1370
e 182 1
e 183 1
e 184 1
e 185 1
e 186 1
e 187 1
e 188 1
e 189 1
e 190 1
e 190 1609
e 191 1
e 192 1
e 193 1
e 194 1
e 194 748
e 194 1609
e 195 1
e 195 1609
e 196 1
e 197 1
e 198 1
e 199 1
e 200 1
e 200 1609
e 201 1
e 202 1
e 203 1
e 203 748
e 204 1
e 204 748
e 205 1
e 206 1
e 206 748
e 206 1370
e 206 1609
e 207 1
e 208 1
e 208 748
e 208 1609
e 209 1
e 209 748
e 210 1
e 211 1
e 212 1
e 213 1
e 214 1
e 214 748
e 214 1370
e 215 1
e 215 748
e 216 1
e 217 1
e 218 1
e 219 1
e 220 1
e 220 748
e 220 1370
e 220 1609
e 221 1
e 222 1
e 222 1609
e 223 1
e 223 1370
e 224 1
e 225 1
e 226 1
e 226 748
e 227 1
e 228 1
e 229 1
e 229 1609
e 230 1
e 231 1
e 232 1
e 233 1
e 234 1
e 234 748
e 235 1
e 236 1
e 237 1
e 237 1609
e 238 1
e 239 1
e 239 748
e 239 1370
e 239 1609
e 240 1
e 240 748
e 241 1
e 242 1
e 243 1
e 244 1
e 245 1
e 245 1370
e 246 1
e 247 1
e 247 748
e 248 1
e 248 1370
e 248 1609
e 249 1
e 250 1
e 251 1
e 252 1
e 253 1
e 254 1
e 255 1
e 255 748
e 255 1370
e 255 1609
e 256 1
e 257 1
e 258 1
e 259 1
e 259 748
e 260 1
e 261 1
e 262 1
e 263 1
e 264 1
e 264 1609
e 265 1
e 265 1370
e 266 1
e 266 748
e 266 1370
e 266 1609
e 267 1
e 267 748
e 267 1370
e 268 1
e 269 1
e 269 748
e 269 1370
e 270 1
e 270 748
e 270 1370
e 271 1
e 272 1
e 273 1
e 274 1
e 275 1
e 275 748
e 276 1
e 277 1
e 278 1
e 279 1
e 280 1
e 280 748
e 281 1
e 282 1
e 283 1
e 284 1
e 285 1
e 285 748
e 286 1
e 287 1
e 288 1
e 289 1
e 290 1
e 291 1
e 292 1
e 293 1
e 294 1
e 295 1
e 295 748
e 296 1
e 296 1370
e 297 1
e 298 1
e 299 1
e 299 748
e 300 1
e 301 1
e 301 748
e 301 1609
e 302 1
e 303 1
e 303 1370
e 304 1
e 305 1
e 306 1
e 307 1
e 308 1
e 309 1
e 309 748
e 309 1370
e 309 1609
e 310 1
e 311 1
e 312 1
e 313 1
e 314 1
e 315 1
e 316 1
e 316 1370
e 317 1
e 318 1
e 318 748
e 319 1
e 320 1
e 320 1370
e 321 1
e 322 1
e 323 1
e 323 1609
e 324 1
e 325 1
e 326 1
e 327 1
e 328 1
e 329 1
e 330 1
e 331 1
e 332 1
e 333 1
e 334 1
e 335 1
e 336 1
e 337 1
e 337 1609
e 338 1
e 339 1
e 340 1
e 341 1
e 342 1
e 343 1
e 344 1
e 345 1
e 346 1
e 347 1
e 348 1
e 349 1
e 349 748
e 349 1370
e 350 1
e 351 1
e 352 1
e 353 1
e 353 1370
e 353 1609
e 354 1
e 355 1
e 355 748
e 355 1370
e 356 1
e 357 1
e 358 1
e 358 748
e 358 1370
e 359 1
e 360 1
e 361 1
e 362 1
e 362 748
e 362 1370
e 362 1609
e 363 1
e 364 1
e 365 1
e 366 1
e 366 748
e 366 1370
e 367 1
e 367 748
e 368 1
e 369 1
e 370 1
e 371 1
e 372 1
e 372 1370
e 372 1609
e 373 1
e 373 748
e 374 1
e 375 1
e 376 1
e 377 1
e 377 748
e 377 1370
e 377 1609
e 378 1
e 379 1
e 380 1
e 381 1
e 382 1
e 383 1
e 384 1
e 385 1
e 386 1
e 387 1
e 388 1
e 389 1
e 389 748
e 389 1370
e 389 1609
e 390 1
e 390 748
e 390 1370
e 391 1
e 392 1
e 393 1
e 394 1
e 395 1
e 396 1
e 397 1
e 398 1
e 398 748
e 399 1
e 400 1
e 400 1609
e 401 1
e 402 1
e 403 1
e 404 1
e 405 1
e 406 1
e 406 748
e 407 1
e 408 1
e 408 1609
e 409 1
e 409 1370
e 410 1
e 411 1
e 411 748
e 411 1370
e 412 1
e 413 1
e 414 1
e 414 1370
e 414 1609
e 415 1
e 415 1609
e 416 1
e 417 1
e 418 1
e 419 1
e 420 1
e 421 1
e 422 1
e 422 1370
e 423 1
e 424 1
e 425 1
e 425 748
e 425 1370
e 426 1
e 427 1
e 427 1370
e 428 1
e 429 1
e 429 748
e 429 1370
e 430 1
e 431 1
e 432 1
e 433 1
e 434 1
e 435 1
e 436 1
e 436 1609
e 437 1
e 438 1
e 439 1
e 440 1
e 441 1
e 441 748
e 442 1
e 443 1
e 443 748
e 443 1370
e 443 1609
e 444 1
e 445 1
e 445 748
e 445 1370
e 446 1
e 447 1
e 448 1
e 449 1
e 450 1
e 450 748
e 450 1609
e 451 1
e 451 1370
e 451 1609
e 452 1
e 453 1
e 454 1
e 455 1
e 456 1
e 457 1
e 458 1
e 459 1
e 460 1
e 461 1
e 462 1
e 463 1
e 463 748
e 464 1
e 465 1
e 466 1
e 467 1
e 468 1
e 469 1
e 470 1
e 471 1
e 472 1
e 472 1370
e 473 1
e 474 1
e 475 1
e 476 1
e 476 1609
e 477 1
e 477 748
e 477 1370
e 478 1
e 479 1
e 480 1
e 481 1
e 481 748
e 481 1370
e 481 1609
e 482 1
e 483 1
e 484 1
e 485 1
e 485 748
e 485 1370
e 485 1609
e 486 1
e 487 1
e 487 748
e 487 1370
e 487 1609
e 488 1
e 489 1
e 490 1
e 491 1
e 492 1
e 493 1
e 494 1
e 494 1609
e 495 1
e 496 1
e 497 1
e 498 1
e 499 1
e 500 1
e 501 1
e 502 1
e 503 1
e 504 1
e 504 748
e 505 1
e 506 1
e 506 748
e 507 1
e 508 1
e 509 1
e 509 748
e 509 1370
e 510 1
e 511 1
e 512 1
e 512 748
e 513 1
e 513 748
e 514 1
e 515 1
e 516 1
e 517 1
e 518 1
e 518 1609
e 519 1
e 520 1
e 521 1
e 521 1370
e 521 1609
e 522 1
e 523 1
e 523 748
e 523 1370
e 523 1609
e 524 1
e 525 1
e 526 1
e 527 1
e 528 1
e 529 1
e 530 1
e 530 1609
e 531 1
e 532 1
e 532 1370
e 533 1
e 534 1
e 535 1
e 536 1
e 537 1
e 538 1
e 539 1
e 540 1
e 541 1
e 542 1
e 543 1
e 544 1
e 545 1
e 546 1
e 547 1
e 548 1
e 548 748
e 549 1
e 550 1
e 551 1
e 552 1
e 553 1
e 554 1
e 555 1
e 556 1
e 557 1
e 557 748
e 558 1
e 559 1
e 559 1370
e 560 1
e 560 748
e 560 1370
e 561 1
e 561 748
e 561 1370
e 561 1609
e 562 1
e 563 1
e 564 1
e 564 748
e 565 1
e 566 1
e 567 1
e 568 1
e 568 748
e 568 1370
e 569 1
e 570 1
e 571 1
e 572 1
e 572 748
e 573 1
e 574 1
e 574 748
e 574 1370
e 575 1
e 576 1
e 577 1
e 578 1
e 578 748
e 579 1
e 579 748
e 580 1
e 581 1
e 582 1
e 583 1
e 583 748
e 584 1
e 585 1
e 586 1
e 587 1
e 588 1
e 589 1
e 590 1
e 590 1370
e 591 1
e 592 1
e 593 1
e 593 748
e 594 1
e 594 748
e 594 1370
e 595 1
e 596 1
e 597 1
e 598 1
e 598 748
e 599 1
e 600 1
e 601 1
e 601 1370
e 602 1
e 603 1
e 604 1
e 605 1
e 606 1
e 607 1
e 608 1
e 609 1
e 610 1
e 610 748
e 610 1609
e 611 1
e 612 1
e 613 1
e 614 1
e 615 1
e 616 1
e 617 1
e 618 1
e 619 1
e 620 1
e 621 1
e 622 1
e 623 1
e 624 1
e 625 1
e 626 1
e 627 1
e 628 1
e 628 1370
e 628 1609
e 629 1
e 629 748
e 630 1
e 630 748
e 630 1370
e 631 1
e 632 1
e 633 1
e 633 748
e 633 1609
e 634 1
e 635 1
e 636 1
e 637 1
e 637 748
e 638 1
e 639 1
e 640 1
e 640 748
e 641 1
e 641 748
e 642 1
e 642 748
e 643 1
e 643 748
e 643 1370
e 644 1
e 644 1609
e 645 1
e 646 1
e 647 1
e 647 748
e 647 1370
e 647 1609
e 648 1
e 649 1
e 650 1
e 651 1
e 651 748
e 651 1370
e 652 1
e 653 1
e 654 1
e 655 1
e 656 1
e 657 1
e 658 1
e 659 1
e 660 1
e 661 1
e 662 1
e 663 1
e 664 1
e 665 1
e 666 1
e 667 1
e 668 1
e 669 1
e 670 1
e 671 1
e 672 1
e 673 1
e 674 1
e 675 1
e 676 1
e 677 1
e 678 1
e 679 1
e 680 1
e 681 1
e 682 1
e 683 1
e 684 1
e 685 1
e 685 748
e 686 1
e 687 1
e 688 1
e 688 1370
e 689 1
e 690 1
e 690 748
e 691 1
e 692 1
e 693 1
e 694 1
e 695 1
e 696 1
e 697 1
e 698 1
e 699 1
e 700 1
e 701 1
e 702 1
e 702 1609
e 703 1
e 704 1
e 705 1
e 706 1
e 706 748
e 707 1
e 708 1
e 709 1
e 710 1
e 711 1
e 712 1
e 713 1
e 714 1
e 715 1
e 716 1
e 717 1
e 717 748
e 718 1
e 719 1
e 720 1
e 721 1
e 722 1
e 723 1
e 723 748
e 724 1
e 725 1
e 726 1
e 727 1
e 727 748
e 727 1370
e 728 1
e 728 1370
e 729 1
e 730 1
e 731 1
e 732 1
e 733 1
e 734 1
e 734 748
e 735 1
e 736 1
e 737 1
e 738 1
e 739 1
e 740 1
e 741 1
e 742 1
e 742 748
e 742 1370
e 743 1
e 744 1
e 745 1
e 746 1
e 747 748
e 749 748
e 749 1370
e 749 1609
e 750 748
e 750 1370
e 751 748
e 752 748
e 753 748
e 754 748
e 754 1370
e 755 748
e 755 1370
e 755 1609
e 756 748
e 757 748
e 758 748
e 759 748
e 759 1370
e 759 1609
e 760 748
e 760 1370
e 761 748
e 762 748
e 762 1609
e 763 748
e 764 748
e 764 1609
e 765 748
e 765 1370
e 765 1609
e 766 748
e 767 748
e 767 1370
e 768 748
e 768 1370
e 768 1609
e 769 748
e 770 748
e 770 1370
e 770 1609
e 771 748
e 771 1370
e 771 1609
e 772 748
e 772 1370
e 773 748
e 774 748
e 774 1370
e 775 748
e 775 1370
e 775 1609
e 776 748
e 777 748
e 778 748
e 779 748
e 780 748
e 781 748
e 782 748
e 782 1370
e 783 748
e 783 1370
e 783 1609
e 784 748
e 784 1370
e 784 1609
e 785 748
e 785 1609
e 786 748
e 787 748
e 787 1370
e 788 748
e 789 748
e 790 748
e 790 1370
e 790 1609
e 791 748
e 791 1370
e 792 748
e 792 1370
e 792 1609
e 793 748
e 794 748
e 794 1370
e 794 1609
e 795 748
e 795 1609
e 796 748
e 797 748
e 798 748
e 798 1370
e 798 1609
e 799 748
e 800 748
e 800 1370
e 800 1609
e 801 748
e 801 1370
e 801 1609
e 802 748
e 802 1370
e 802 1609
e 803 748
e 804 748
e 804 1370
e 804 1609
e 805 748
e 806 748
e 806 1370
e 806 1609
e 807 748
e 807 1370
e 807 1609
e 808 748
e 808 1370
e 808 1609
e 809 748
e 809 1370
e 810 748
e 810 1370
e 810 1609
e 811 748
e 811 1609
e 812 748
e 812 1370
e 812 1609
e 813 748
e 813 1609
e 814 748
e 814 1370
e 815 748
e 815 1370
e 816 748
e 817 748
e 817 1370
e 817 1609
e 818 748
e 819 748
e 819 1370
e 819 1609
e 820 748
e 821 748
e 822 748
e 822 1370
e 823 748
e 823 1370
e 824 748
e 825 748
e 825 1370
e 825 1609
e 826 748
e 827 748
e 827 1370
e 827 1609
e 828 748
e 828 1370
e 829 748
e 830 748
e 830 1370
e 831 748
e 831 1370
e 832 748
e 832 1370
e 833 748
e 833 1370
e 834 748
e 834 1609
e 835 748
e 836 748
e 837 748
e 837 1370
e 837 1609
e 838 748
e 838 1370
e 839 748
e 840 748
e 840 1370
e 840 1609
e 841 748
e 842 748
e 843 748
e 843 1370
e 844 748
e 845 748
e 845 1370
e 846 748
e 846 1370
e 846 1609
e 847 748
e 847 1370
e 847 1609
e 848 748
e 849 748
e 849 1370
e 850 748
e 850 1370
e 851 748
e 851 1370
e 851 1609
e 852 748
e 853 748
e 853 1370
e 853 1609
e 854 748
e 854 1370
e 854 1609
e 855 748
e 855 1370
e 855 1609
e 856 748
e 857 748
e 857 1370
e 858 748
e 858 1370
e 858 1609
e 859 748
e 859 1370
e 860 748
e 861 748
e 861 1370
e 861 1609
e 862 748
e 863 748
e 864 748
e 864 1370
e 865 748
e 865 1370
e 865 1609
e 866 748
e 867 748
e 867 1370
e 868 748
e 868 1370
e 868 1609
e 869 748
e 869 1370
e 869 1609
e 870 748
e 871 748
e 871 1609
e 872 748
e 873 748
e 873 1370
e 874 748
e 874 1370
e 874 1609
e 875 748
e 875 1370
e 875 1609
e 876 748
e 876 1370
e 876 1609
e 877 748
e 877 1370
e 877 1609
e 878 748
e 878 1370
e 878 1609
e 879 748
e 880 748
e 880 1370
e 881 748
e 881 1370
e 881 1609
e 882 748
e 883 748
e 883 1370
e 883 1609
e 884 748
e 884 1370
e 885 748
e 885 1609
e 886 748
e 886 1370
e 886 1609
e 887 748
e 888 748
e 888 1370
e 888 1609
e 889 748
e 889 1370
e 889 1609
e 890 748
e 890 1370
e 890 1609
e 891 748
e 892 748
e 893 748
e 893 1370
e 893 1609
e 894 748
e 894 1609
e 895 748
e 896 748
e 897 748
e 897 1370
e 897 1609
e 898 748
e 898 1370
e 899 748
e 900 748
e 900 1370
e 901 748
e 901 1370
e 902 748
e 903 748
e 903 1370
e 903 1609
e 904 748
e 905 748
e 906 748
e 906 1370
e 907 748
e 907 1370
e 907 1609
e 908 748
e 908 1370
e 909 748
e 910 748
e 910 1609
e 911 748
e 911 1370
e 911 1609
e 912 748
e 912 1609
e 913 748
e 914 748
e 914 1370
e 914 1609
e 915 748
e 915 1370
e 916 748
e 917 748
e 917 1370
e 917 1609
e 918 748
e 918 1370
e 918 1609
e 919 748
e 919 1370
e 920 748
e 920 1370
e 920 1609
e 921 748
e 922 748
e 923 748
e 923 1370
e 924 748
e 924 1370
e 925 748
e 926 748
e 926 1370
e 926 1609
e 927 748
e 927 1370
e 927 1609
e 928 748
e 928 1370
e 928 1609
e 929 748
e 930 748
e 931 748
e 932 748
e 932 1370
e 933 748
e 933 1609
e 934 748
e 935 748
e 935 1370
e 935 1609
e 936 748
e 936 1370
e 936 1609
e 937 748
e 938 748
e 938 1370
e 938 1609
e 939 748
e 939 1370
e 939 1609
e 940 748
e 940 1370
e 941 748
e 941 1370
e 942 748
e 942 1370
e 942 1609
e 943 748
e 943 1370
e 943 1609
e 944 748
e 945 748
e 945 1370
e 945 1609
e 946 748
e 946 1609
e 947 748
e 947 1609
e 948 748
e 948 1370
e 948 1609
e 949 748
e 949 1609
e 950 748
e 950 1370
e 951 748
e 951 1370
e 951 1609
e 952 748
e 952 1370
e 953 748
e 953 1370
e 953 1609
e 954 748
e 954 1609
e 955 748
e 955 1370
e 955 1609
e 956 748
e 956 1370
e 956 1609
e 957 748
e 957 1370
e 957 1609
e 958 748
e 959 748
e 959 1370
e 960 748
e 960 1370
e 961 748
e 962 748
e 962 1370
e 962 1609
e 963 748
e 963 1370
e 964 748
e 964 1370
e 964 1609
e 965 748
e 965 1370
e 965 1609
e 966 748
e 966 1370
e 967 748
e 967 1370
e 968 748
e 968 1370
e 969 748
e 969 1370
e 970 748
e 970 1609
e 971 748
e 971 1370
e 971 1609
e 972 748
e 972 1370
e 973 748
e 974 748
e 975 748
e 975 1370
e 976 748
e 977 748
e 978 748
e 978 1370
e 979 748
e 980 748
e 980 1370
e 981 748
e 981 1370
e 982 748
e 982 1370
e 982 1609
e 983 748
e 983 1370
e 983 1609
e 984 748
e 984 1370
e 984 1609
e 985 748
e 985 1370
e 985 1609
e 986 748
e 986 1370
e 987 748
e 987 1370
e 988 748
e 989 748
e 989 1370
e 990 748
e 990 1370
e 990 1609
e 991 748
e 991 1370
e 991 1609
e 992 748
e 992 1370
e 992 1609
e 993 748
e 994 748
e 994 1370
e 994 1609
e 995 748
e 995 1370
e 995 1609
e 996 748
e 996 1370
e 997 748
e 997 1370
e 998 748
e 998 1370
e 998 1609
e 999 748
e 999 1609
e 1000 748
e 1000 1370
e 1001 748
e 1001 1370
e 1002 748
e 1002 1609
e 1003 748
e 1003 1609
e 1004 748
e 1004 1370
e 1004 1609
e 1005 748
e 1005 1370
e 1005 1609
e 1006 748
e 1006 1370
e 1006 1609
e 1007 748
e 1007 1370
e 1007 1609
e 1008 748
e 1008 1370
e 1009 748
e 1009 1370
e 1010 748
e 1010 1609
e 1011 748
e 1011 1370
e 1012 748
e 1013 748
e 1014 748
e 1014 1370
e 1014 1609
e 1015 748
e 1016 748
e 1016 1609
e 1017 748
e 1017 1370
e 1017 1609
e 1018 748
e 1018 1370
e 1018 1609
e 1019 748
e 1019 1370
e 1019 1609
e 1020 748
e 1021 748
e 1021 1370
e 1021 1609
e 1022 748
e 1022 1370
e 1023 748
e 1023 1370
e 1023 1609
e 1024 748
e 1025 748
e 1025 1370
e 1025 1609
e 1026 748
e 1026 1370
e 1026 1609
e 1027 748
e 1027 1609
e 1028 748
e 1028 1370
e 1028 1609
e 1029 748
e 1030 748
e 1030 1370
e 1031 748
e 1032 748
e 1032 1370
e 1033 748
e 1033 1370
e 1033 1609
e 1034 748
e 1034 1370
e 1034 1609
e 1035 748
e 1035 1609
e 1036 748
e 1036 1370
e 1037 748
e 1037 1370
e 1037 1609
e 1038 748
e 1039 748
e 1039 1370
e 1039 1609
e 1040 748
e 1040 1370
e 1040 1609
e 1041 748
e 1041 1370
e 1041 1609
e 1042 748
e 1042 1370
e 1043 748
e 1043 1609
e 1044 748
e 1044 1370
e 1045 748
e 1046 748
e 1046 1370
e 1046 1609
e 1047 748
e 1047 1370
e 1047 1609
e 1048 748
e 1048 1370
e 1048 1609
e 1049 748
e 1049 1609
e 1050 748
e 1051 748
e 1051 1370
e 1051 1609
e 1052 748
e 1052 1370
e 1053 748
e 1054 748
e 1054 1370
e 1054 1609
e 1055 748
e 1055 1609
e 1056 748
e 1056 1370
e 1057 748
e 1058 748
e 1058 1370
e 1058 1609
e 1059 748
e 1059 1370
e 1059 1609
e 1060 748
e 1060 1370
e 1060 1609
e 1061 748
e 1061 1370
e 1061 1609
e 1062 748
e 1063 748
e 1063 1370
e 1063 1609
e 1064 748
e 1065 748
e 1065 1370
e 1065 1609
e 1066 748
e 1067 748
e 1068 748
e 1069 748
e 1069 1370
e 1070 748
e 1070 1370
e 1070 1609
e 1071 748
e 1072 748
e 1073 748
e 1074 748
e 1074 1370
e 1074 1609
e 1075 748
e 1075 1370
e 1075 1609
e 1076 748
e 1076 1370
e 1076 1609
e 1077 748
e 1077 1370
e 1078 748
e 1078 1370
e 1079 748
e 1079 1370
e 1080 748
e 1080 1370
e 1080 1609
e 1081 748
e 1082 748
e 1082 1370
e 1083 748
e 1083 1370
e 1084 748
e 1084 1370
e 1084 1609
e 1085 748
e 1086 748
e 1087 748
e 1087 1370
e 1087 1609
e 1088 748
e 1088 1370
e 1089 748
e 1089 1609
e 1090 748
e 1090 1370
e 1091 748
e 1091 1609
e 1092 748
e 1092 1370
e 1093 748
e 1094 748
e 1094 1370
e 1095 748
e 1095 1609
e 1096 748
e 1096 1370
e 1096 1609
e 1097 748
e 1097 1370
e 1097 1609
e 1098 748
e 1099 748
e 1099 1370
e 1099 1609
e 1100 748
e 1100 1609
e 1101 748
e 1101 1370
e 1101 1609
e 1102 748
e 1102 1370
e 1102 1609
e 1103 748
e 1103 1370
e 1103 1609
e 1104 748
e 1105 748
e 1106 748
e 1107 748
e 1108 748
e 1108 1370
e 1109 748
e 1109 1370
e 1110 748
e 1111 748
e 1111 1370
e 1111 1609
e 1112 748
e 1112 1609
e 1113 748
e 1113 1370
e 1114 748
e 1114 1370
e 1114 1609
e 1115 748
e 1115 1370
e 1116 748
e 1116 1370
e 1117 748
e 1117 1370
e 1117 1609
e 1118 748
e 1118 1370
e 1118 1609
e 1119 748
e 1119 1370
e 1119 1609
e 1120 748
e 1120 1370
e 1120 1609
e 1121 748
e 1121 1370
e 1121 1609
e 1122 748
e 1122 1370
e 1123 748
e 1123 1370
e 1124 748
e 1124 1370
e 1125 748
e 1125 1370
e 1125 1609
e 1126 748
e 1126 1370
e 1127 748
e 1128 748
e 1128 1370
e 1128 1609
e 1129 748
e 1129 1370
e 1129 1609
e 1130 748
e 1131 748
e 1132 748
e 1132 1370
e 1132 1609
e 1133 748
e 1134 748
e 1135 748
e 1135 1609
e 1136 748
e 1136 1370
e 1136 1609
e 1137 748
e 1138 748
e 1139 748
e 1140 748
e 1140 1370
e 1140 1609
e 1141 748
e 1142 748
e 1142 1370
e 1142 1609
e 1143 748
e 1143 1370
e 1144 748
e 1145 748
e 1146 748
e 1147 748
e 1147 1370
e 1147 1609
e 1148 748
e 1148 1370
e 1149 748
e 1149 1370
e 1149 1609
e 1150 748
e 1151 748
e 1152 748
e 1152 1609
e 1153 748
e 1154 748
e 1155 748
e 1155 1370
e 1155 1609
e 1156 748
e 1156 1370
e 1157 748
e 1157 1370
e 1158 748
e 1159 748
e 1160 748
e 1160 1370
e 1161 748
e 1161 1370
e 1162 748
e 1162 1370
e 1163 748
e 1163 1370
e 1163 1609
e 1164 748
e 1164 1609
e 1165 748
e 1165 1609
e 1166 748
e 1166 1370
e 1166 1609
e 1167 748
e 1167 1370
e 1167 1609
e 1168 748
e 1168 1370
e 1169 748
e 1169 1609
e 1170 748
e 1170 1609
e 1171 748
e 1171 1370
e 1171 1609
e 1172 748
e 1172 1370
e 1172 1609
e 1173 748
e 1173 1370
e 1173 1609
e 1174 748
e 1175 748
e 1176 748
e 1176 1370
e 1176 1609
e 1177 748
e 1177 1370
e 1177 1609
e 1178 748
e 1178 1370
e 1178 1609
e 1179 748
e 1179 1370
e 1179 1609
e 1180 748
e 1180 1609
e 1181 748
e 1182 748
e 1182 1370
e 1182 1609
e 1183 748
e 1183 1370
e 1183 1609
e 1184 748
e 1185 748
e 1186 748
e 1187 748
e 1188 748
e 1188 1370
e 1188 1609
e 1189 748
e 1190 748
e 1190 1370
e 1190 1609
e 1191 748
e 1191 1609
e 1192 748
e 1192 1370
e 1192 1609
e 1193 748
e 1193 1370
e 1194 748
e 1195 748
e 1196 748
e 1197 748
e 1197 1370
e 1198 748
e 1199 748
e 1199 1370
e 1200 748
e 1200 1370
e 1200 1609
e 1201 748
e 1202 748
e 1202 1370
e 1202 1609
e 1203 748
e 1203 1370
e 1203 1609
e 1204 748
e 1204 1370
e 1205 748
e 1205 1370
e 1206 748
e 1207 748
e 1207 1609
e 1208 748
e 1208 1370
e 1208 1609
e 1209 748
e 1209 1370
e 1209 1609
e 1210 748
e 1210 1370
e 1210 1609
e 1211 748
e 1211 1370
e 1211 1609
e 1212 748
e 1212 1370
e 1212 1609
e 1213 748
e 1213 1370
e 1214 748
e 1214 1370
e 1215 748
e 1215 1370
e 1215 1609
e 1216 748
e 1216 1370
e 1216 1609
e 1217 748
e 1217 1609
e 1218 748
e 1218 1370
e 1218 1609
e 1219 748
e 1219 1370
e 1220 748
e 1221 748
e 1221 1609
e 1222 748
e 1222 1370
e 1222 1609
e 1223 748
e 1224 748
e 1224 1370
e 1225 748
e 1225 1370
e 1225 1609
e 1226 748
e 1226 1370
e 1226 1609
e 1227 748
e 1227 1370
e 1227 1609
e 1228 748
e 1228 1370
e 1228 1609
e 1229 748
e 1229 1609
e 1230 748
e 1230 1370
e 1230 1609
e 1231 748
e 1232 748
e 1232 1370
e 1233 748
e 1234 748
e 1235 748
e 1235 1609
e 1236 748
e 1236 1370
e 1236 1609
e 1237 748
e 1237 1370
e 1237 1609
e 1238 748
e 1238 1370
e 1239 748
e 1239 1370
e 1239 1609
e 1240 748
e 1240 1370
e 1241 748
e 1242 748
e 1242 1370
e 1243 748
e 1243 1370
e 1243 1609
e 1244 748
e 1244 1370
e 1244 1609
e 1245 748
e 1246 748
e 1246 1370
e 1246 1609
e 1247 748
e 1247 1370
e 1248 748
e 1248 1370
e 1248 1609
e 1249 748
e 1249 1370
e 1249 1609
e 1250 748
e 1250 1370
e 1250 1609
e 1251 748
e 1251 1370
e 1251 1609
e 1252 748
e 1252 1370
e 1253 748
e 1253 1609
e 1254 748
e 1254 1370
e 1254 1609
e 1255 748
e 1256 748
e 1256 1609
e 1257 748
e 1257 1370
e 1258 748
e 1258 1370
e 1258 1609
e 1259 748
e 1259 1370
e 1260 748
e 1261 748
e 1261 1370
e 1261 1609
e 1262 748
e 1262 1370
e 1263 748
e 1263 1609
e 1264 748
e 1264 1370
e 1265 748
e 1265 1370
e 1266 748
e 1267 748
e 1267 1370
e 1267 1609
e 1268 748
e 1269 748
e 1269 1370
e 1269 1609
e 1270 748
e 1270 1370
e 1270 1609
e 1271 748
e 1271 1370
e 1271 1609
e 1272 748
e 1272 1370
e 1272 1609
e 1273 748
e 1273 1609
e 1274 748
e 1275 748
e 1275 1370
e 1276 748
e 1276 1370
e 1277 748
e 1278 748
e 1278 1370
e 1278 1609
e 1279 748
e 1279 1370
e 1279 1609
e 1280 748
e 1280 1609
e 1281 748
e 1282 748
e 1283 748
e 1283 1370
e 1284 748
e 1285 748
e 1285 1370
e 1285 1609
e 1286 748
e 1287 748
e 1287 1370
e 1288 748
e 1288 1370
e 1289 748
e 1289 1370
e 1290 748
e 1290 1609
e 1291 748
e 1292 748
e 1293 748
e 1293 1370
e 1294 748
e 1295 748
e 1295 1370
e 1295 1609
e 1296 748
e 1296 1370
e 1296 1609
e 1297 748
e 1297 1370
e 1297 1609
e 1298 748
e 1298 1370
e 1299 748
e 1299 1370
e 1299 1609
e 1300 748
e 1300 1370
e 1301 748
e 1301 1370
e 1301 1609
e 1302 748
e 1302 1370
e 1303 748
e 1303 1370
e 1303 1609
e 1304 748
e 1304 1370
e 1304 1609
e 1305 748
e 1305 1370
e 1306 748
e 1307 748
e 1308 748
e 1308 1370
e 1308 1609
e 1309 748
e 1309 1370
e 1309 1609
e 1310 748
e 1310 1370
e 1311 748
e 1311 1370
e 1311 1609
e 1312 748
e 1312 1609
e 1313 748
e 1313 1370
e 1313 1609
e 1314 748
e 1314 1370
e 1314 1609
e 1315 748
e 1316 748
e 1317 748
e 1318 748
e 1318 1370
e 1319 748
e 1320 748
e 1320 1370
e 1320 1609
e 1321 748
e 1321 1370
e 1321 1609
e 1322 748
e 1322 1370
e 1323 748
e 1323 1370
e 1323 1609
e 1324 748
e 1324 1370
e 1324 1609
e 1325 748
e 1325 1370
e 1325 1609
e 1326 748
e 1326 1370
e 1326 1609
e 1327 748
e 1327 1370
e 1327 1609
e 1328 748
e 1328 1370
e 1329 748
e 1329 1370
e 1330 748
e 1330 1370
e 1330 1609
e 1331 748
e 1332 748
e 1333 748
e 1333 1370
e 1333 1609
e 1334 748
e 1334 1370
e 1334 1609
e 1335 748
e 1335 1370
e 1336 748
e 1336 1609
e 1337 748
e 1337 1370
e 1337 1609
e 1338 748
e 1339 748
e 1339 1370
e 1340 748
e 1340 1609
e 1341 748
e 1341 1370
e 1341 1609
e 1342 748
e 1342 1370
e 1342 1609
e 1343 748
e 1343 1370
e 1343 1609
e 1344 748
e 1344 1370
e 1344 1609
e 1345 748
e 1345 1370
e 1346 748
e 1346 1370
e 1346 1609
e 1347 748
e 1347 1370
e 1348 748
e 1349 748
e 1350 748
e 1350 1370
e 1350 1609
e 1351 748
e 1351 1370
e 1352 748
e 1352 1370
e 1352 1609
e 1353 748
e 1354 748
e 1354 1370
e 1354 1609
e 1355 748
e 1356 748
e 1356 1370
e 1357 748
e 1358 748
e 1358 1370
e 1358 1609
e 1359 748
e 1360 748
e 1360 1370
e 1361 748
e 1362 748
e 1362 1370
e 1363 748
e 1363 1609
e 1364 748
e 1364 1609
e 1365 748
e 1366 748
e 1366 1370
e 1366 1609
e 1367 748
e 1368 748
e 1368 1370
e 1369 1370
e 1369 1609
e 1371 1370
e 1372 1370
e 1373 1370
e 1374 1370
e 1374 1609
e 1375 1370
e 1376 1370
e 1377 1370
e 1378 1370
e 1379 1370
e 1380 1370
e 1381 1370
e 1382 1370
e 1383 1370
e 1384 1370
e 1385 1370
e 1386 1370
e 1387 1370
e 1388 1370
e 1389 1370
e 1390 1370
e 1391 1370
e 1392 1370
e 1393 1370
e 1393 1609
e 1394 1370
e 1395 1370
e 1396 1370
e 1397 1370
e 1398 1370
e 1399 1370
e 1400 1370
e 1401 1370
e 1402 1370
e 1403 1370
e 1404 1370
e 1405 1370
e 1406 1370
e 1407 1370
e 1408 1370
e 1409 1370
e 1410 1370
e 1411 1370
e 1412 1370
e 1413 1370
e 1414 1370
e 1415 1370
e 1416 1370
e 1417 1370
e 1418 1370
e 1418 1609
e 1419 1370
e 1420 1370
e 1421 1370
e 1422 1370
e 1423 1370
e 1423 1609
e 1424 1370
e 1425 1370
e 1426 1370
e 1426 1609
e 1427 1370
e 1428 1370
e 1429 1370
e 1430 1370
e 1431 1370
e 1432 1370
e 1433 1370
e 1434 1370
e 1435 1370
e 1436 1370
e 1437 1370
e 1438 1370
e 1438 1609
e 1439 1370
e 1440 1370
e 1440 1609
e 1441 1370
e 1442 1370
e 1443 1370
e 1444 1370
e 1444 1609
e 1445 1370
e 1445 1609
e 1446 1370
e 1447 1370
e 1447 1609
e 1448 1370
e 1448 1609
e 1449 1370
e 1450 1370
e 1451 1370
e 1451 1609
e 1452 1370
e 1453 1370
e 1454 1370
e 1454 1609
e 1455 1370
e 1456 1370
e 1456 1609
e 1457 1370
e 1458 1370
e 1459 1370
e 1460 1370
e 1460 1609
e 1461 1370
e 1461 1609
e 1462 1370
e 1463 1370
e 1464 1370
e 1464 1609
e 1465 1370
e 1465 1609
e 1466 1370
e 1467 1370
e 1467 1609
e 1468 1370
e 1469 1370
e 1469 1609
e 1470 1370
e 1471 1370
e 1472 1370
e 1473 1370
e 1473 1609
e 1474 1370
e 1475 1370
e 1476 1370
e 1477 1370
e 1478 1370
e 1479 1370
e 1480 1370
e 1481 1370
e 1481 1609
e 1482 1370
e 1483 1370
e 1483 1609
e 1484 1370
e 1485 1370
e 1486 1370
e 1487 1370
e 1488 1370
e 1489 1370
e 1490 1370
e 1491 1370
e 1492 1370
e 1493 1370
e 1494 1370
e 1495 1370
e 1496 1370
e 1497 1370
e 1497 1609
e 1498 1370
e 1498 1609
e 1499 1370
e 1500 1370
e 1501 1370
e 1502 1370
e 1503 1370
e 1503 1609
e 1504 1370
e 1505 1370
e 1506 1370
e 1507 1370
e 1508 1370
e 1508 1609
e 1509 1370
e 1509 1609
e 1510 1370
e 1511 1370
e 1512 1370
e 1513 1370
e 1514 1370
e 1515 1370
e 1516 1370
e 1517 1370
e 1518 1370
e 1518 1609
e 1519 1370
e 1520 1370
e 1521 1370
e 1522 1370
e 1522 1609
e 1523 1370
e 1524 1370
e 1525 1370
e 1525 1609
e 1526 1370
e 1527 1370
e 1528 1370
e 1528 1609
e 1529 1370
e 1530 1370
e 1530 1609
e 1531 1370
e 1532 1370
e 1533 1370
e 1534 1370
e 1535 1370
e 1536 1370
e 1537 1370
e 1538 1370
e 1539 1370
e 1540 1370
e 1541 1370
e 1542 1370
e 1543 1370
e 1544 1370
e 1545 1370
e 1546 1370
e 1547 1370
e 1548 1370
e 1548 1609
e 1549 1370
e 1550 1370
e 1551 1370
e 1552 1370
e 1553 1370
e 1554 1370
e 1554 1609
e 1555 1370
e 1555 1609
e 1556 1370
e 1557 1370
e 1558 1370
e 1559 1370
e 1560 1370
e 1561 1370
e 1562 1370
e 1563 1370
e 1564 1370
e 1564 1609
e 1565 1370
e 1566 1370
e 1567 1370
e 1568 1370
e 1569 1370
e 1569 1609
e 1570 1370
e 1571 1370
e 1572 1370
e 1573 1370
e 1574 1370
e 1575 1370
e 1576 1370
e 1577 1370
e 1578 1370
e 1579 1370
e 1580 1370
e 1580 1609
e 1581 1370
e 1582 1370
e 1583 1370
e 1584 1370
e 1585 1370
e 1586 1370
e 1586 1609
e 1587 1370
e 1588 1370
e 1588 1609
e 1589 1370
e 1590 1370
e 1591 1370
e 1592 1370
e 1593 1370
e 1593 1609
e 1594 1370
e 1594 1609
e 1595 1370
e 1596 1370
e 1597 1370
e 1598 1370
e 1598 1609
e 1599 1370
e 1599 1609
e 1600 1370
e 1601 1370
e 1602 1370
e 1603 1370
e 1604 1370
e 1605 1370
e 1606 1370
e 1606 1609
e 1607 1370
e 1607 1609
e 1608 1370
e 1608 1609
e 1610 1609
e 1611 1609
e 1612 1609
e 1613 1609
e 1614 1609
e 1615 1609
e 1616 1609
e 1617 1609
e 1618 1609
e 1619 1609
e 1620 1609
e 1621 1609
e 1622 1609
e 1623 1609
e 1624 1609
e 1625 1609
e 1626 1609
e 1627 1609
e 1628 1609
e 1629 1609
e 1630 1609
e 1631 1609
e 1632 1609
e 1633 1609
e 1634 1609
e 1635 1609
e 1636 1609
e 1637 1609
e 1638 1609
e 1639 1609
e 1640 1609
e 1641 1609
e 1642 1609
e 1643 1609
e 1644 1609
e 1645 1609
e 1646 1609
e 1647 1609
e 1648 1609
e 1649 1609
e 1650 1609
e 1651 1609
e 1652 1609
e 1653 1609
e 1654 1609
e 1655 1609
e 1656 1609
e 1657 1609
e 1658 1609
e 1659 1609
e 1660 1609
e 1661 1609
e 1662 1609
e 1663 1609
e 1664 1609
e 1665 1609
e 1666 1609
e 1667 1609
e 1668 1609
e 1669 1609
e 1670 1609
e 1671 1609
e 1672 1609
e 1673 1609
e 1674 1609
e 1675 1609
e 1676 1609
e 1677 1609
e 1678 1609
e 1679 1609
e 1680 1609
e 1681 1609
e 1682 1609
e 1683 1609
e 1684 1609
e 1685 1609
e 1686 1609
e 1687 1609
e 1688 1609
e 1689 1609
e 1690 1609
e 1691 1609
e 1692 1609
e 1693 1609
e 1694 1609
e 1695 1609
e 1696 1609
e 1697 1609
e 1698 1609
e 1699 1609
e 1700 1609
e 1701 1609
e 1702 1609
e 1703 1609
e 1704 1609
e 1705 1609
e 1706 1609
e 1707 1609
e 1708 1609
e 1709 1609
e 1710 1609
e 1711 1609
e 1712 1609
e 1713 1609
e 1714 1609
e 1715 1609
e 1716 1609
e 1717 1609
e 1718 1609
e 1719 1609
e 1720 1609
e 1721 1609
e 1722 1609
e 1723 1609
e 1724 1609
e 1725 1609
e 1726 1609
e 1727 1609
e 1728 1609
e 1729 1609
e 1730 1609
e 1731 1609
e 1732 1609
e 1733 1609
e 1734 1609
e 1735 1609
e 1736 1609
e 1737 1609
e 1738 1609
e 1739 1609
e 1740 1609
e 1741 1609
e 1742 1609
e 1743 1609
e 1744 1609
e 1745 1609
e 1746 1609
e 1747 1609
e 1748 1609
e 1749 1609
e 1750 1609
e 1751 1609
e 1752 1609
e 1753 1609
e 1754 1609
e 1755 1609
e 1756 1609
e 1757 1609
e 1758 1609
e 1759 1609